ESGO 2019 Posters

ePosters by Numbers
ePoster Number   Abstract Title Presenter Firstname Presenter Lastname
EP197 Nipple skin sparing mastectomy by conventional laparoscopic single port: about four cases Julien Bakenga
EP198 A prospective pilot study on use of liquid crystal thermography to detect early breast cancer Pawel Basta
EP199 Nipple areola complex sparing mastectomy on prophylactic and oncologic surgery. Potential impact of its application in a referral centre and literature review. Rocío Bermejo Martínez
EP200 MammaPrint testing can reduce the costs of treatment in breast cancer patients Bojana Crnobrnja
EP201 Free - cell tumor DNA as a biomarker for early breast cancer Bojana Crnobrnja
EP202 A retrospective case-report study of the DNA methylation patterns of RAR-b & RASSF1A genes from breast FNAC samples in a Greek population Konstantinos Dinas
EP204 Post irradiation primary osteosarcoma of the breast: a case report of an extremely rare entity (Poster presentation) Maiar Elghobashy
EP205 Management of subclinical breast cancers: A report of 74 cases Asmàa Fouad
EP206 Serum CA 15.3 and cytokine levels and expression of hormonal receptors in early-stage breast cancer Malgorzata Fuksiewicz
EP207 Evaluation of miRNA-135a and miRNA-9 as prognostic markers in breast cancer patients Mohamed Gamea
EP208 Tumor infiltrating lymphocytes - marker of therapy response in breast cancer George Iancu
EP209 miR-190b-5p expression is a highly reliable discriminator between ER-positive and ER-negative breast cancer Evgeny Imyanitov
EP210 Invasive lobular carcinoma with extracellular mucin production. Presentation of the second case diagnosed within three years in our hospital. Stefania Kokkali
EP211 An unusual case of intramedullary spinal cord metastasis from breast cancer Stefania Kokkali
EP212 Isolated vulvar metastasis of breast cancer of non-special-type after 13 years: a case report Christos Kotanidis
EP213 Undifferentiated pleomorphic sarcoma of the breast. Presentation of a case. Nektarios Koufopoulos
EP214 Sebaceous carcinoma of the breast: a rare presentation Ikram Marghli
EP215 less visible approaches in oncological breast surgery José María Mariconde
EP216 Breast cancer: tissue expander and implant reconstruction José Mariconde
EP217 Frequency of gynaecological symptoms in women treated for up to 5 years with tamoxifen. Somer Masood
EP218 The primitive breast cancer at the woman of less than 35 years in Oran from 1996 to 2014 Houria Messid Bouziane Meflah
EP219 Improvement in quality of life of Indian breast cancer patients by Pre and post mastectomy educational counselling Ashutosh Mishra
EP220 Survival of Filipino Women with Metastatic Brain Disease from Breast Carcinoma who underwent Whole Brain Radiation Therapy in a Cancer Institute in Cebu City from 2005 to 2016 Mariel Mitz Mopon
EP221 Ovarian metastases from breast cancer: series over a 20-years period at a Lebanese tertiary care center Malak Moubarak
EP222 Indocyanine green for sentinel lymph node detection in early breast cancer: prospective evaluation of detection rate and toxicity Charlotte Ngô
EP223 PROGNOSIS FACTORS OF BREAST CANCER (About 557 cases) Oumaima Omran
EP224 Low long-chain polyunsaturated fatty acids levels in breast adipose tissue are associated with multifocality in women with positive hormone receptors tumors Lobna Ouldamer
EP225 characteristics of inflammatory breast cancer within Mohamed VI center for the treatment of cancer, CHU Ibn Rochd, Casablanca Omran Oumaima
EP226 The advancing age: breast cancer over 80 years Ana Carolina Rocha
EP227 Ultrasound and MRI evaluation of axillary lymph nodes in breast cancer patients Maria Dolores Rodriguez Garnica
EP228 Clear Cell Carcinoma of the breast. A rare histological variant with a poor prognosis. Case Report and Literature Review. Imen Sassi
EP229 Breast metastasis from a renal cell cancer. Case Report and Literature Review. Imen Sassi
EP230 Solid papillary carcinoma of the breast: about two cases and literature review. Sarah Sghaier
EP231 ER, PR and HER-2 status in breast cancer - Correlation with clinicopathological characteristics and clinical outcome at a Tertiary Care Centre in South India Deepa Shunmugam
EP232 Clinical prediction factors of prognosis in operable triple negative breast cancer Monika Sobočan
EP234 Breast metastasis from pancreatic neuroendocrine carcinoma misdiagnosed as primary carcinoma. A potential pitfall with significant clinical implications Helen Trihia
EP235 The Effect of Bariatric Surgery on Breast Cancer Dimitra Vasileiadou
EP236 Breast-conserving surgery (BCS) in the management of Carcinoma Ductal in Situ (DCIS): reoperation rates and safety margins Alicia Vazquez Sarandeses
EP237 Survival Outcome and Disease Free Survival of Locally Advanced Cervical Cancer with CT-Detected Para-Aortic Lymph Nodes Joan Kristel Abrenica
EP238 Paraaortic lymph nodes involvement as a prognostic factor in patients with advanced cervical cancer staged by laparoscopy Nuria Agusti
EP239 Risk factor for the postoperative lymphocele in women with cervical cancer treated with radical hysterectomy and pelvic lymphadenectomy Jung Hwan Ahn
EP240 Predictor factors of Lymph node metastases in cervical cancer Huseyin Akilli
EP241 Role of no further treatment after radical hysterectomy in early stage cervical cancer with intermediate risk factors Huseyin Akilli
EP242 Is the depth of cone related to the endocervical glandular involvement in patients who underwent loop electrosurgical excision procedure or cold knife conization? Serkan Akış
EP243 Factors that influence surgical margin state in patients undergoing cold knife conization - a single center experience Igor Aluloski
EP244 Prevalence and Specific-HPV Genotypes Distribution among Women Attending the Ibn Rochd Universitary Hospital in Casablanca ; Morocco Bouziyane Amal
EP246 Reconsidering the role of ErbB receptors status among young patients with CIN 3 and cervical cancer Georgios Androutsopoulos
EP247 Sarcopenia is really prognostic factor of outcome in patients with cervical cancer with concurrent chemoradiotherapy? Yoshihisa Arakaki
EP248 VALHUDES: a protocol for VALidation of HUman papillomavirus assays and collection DEvices for HPV testing on Self-samples and urine samples Marc Arbyn
EP249 Survival in 1B1 Cervical cancer treated radical hysterectomy via open or minimal access approaches at a medium sized cancer centre in the United Kingdom. Viren Asher
EP252 Para-aortic lymph node involvement revisited in the light of the revised 2018 FIGO staging system for cervical cancer: A retrospective, dual-institutional study Ali Ayhan
EP253 Is the revised 2018 FIGO staging system for cervical cancer associated with increased discrimination in prognosis for women previously staged as IB disease?: A retrospective, dual-institutional study Ali Ayhan
EP254 The prognostic value of lymph node ratio in stage IIIC cervical cancer patients triaged to primary treatment by radical hysterectomy with systematic pelvic and para-aortic lymphadenectomy: A retrospective, dual-institutional study Ali Ayhan
EP255 Conditional relative survival of cervical cancer: a Korean central cancer registry study Jaeman Bae
EP256 Inhibition of phosphatidylinositol 3-kinase (PI3K) signaling synergistically potentiate antitumor efficiency of paclitaxel and overcome paclitaxel-mediated resistance in cervical cancer Min Wha Baik
EP257 Early stage cervical cancer treated by preoperative brachytherapy: prognostic factors ans clinical outcomes. Benoit Bataille
EP258 Long - term outcomes of laparoscopic radical hysterectomy (type III PIVER) for early stage cervical cancer (IA1-IB1 FIGO). Igor Berlev
EP259 Comparison of clinical outcomes of squamous cell carcinoma and adenocarcinoma of the uterine cervix in a Portuguese oncological referral center Margarida Bernardino
EP260 Is there still a role for laparoscopic radical hysterectomy? Personalizing surgical approach in early stage cervical cancer. Nicolò Bizzarri
EP261 Cervical cancer tumor size evaluated by preoperative estimation and final pathology report after radical operative procedure and the correlation to survival Signe Frahm Bjørn
EP262 Primary conization overcomes the risk of local recurrence following laparoscopic radical hysterectomy in early-stage cervical cancer Giorgio Bogani
EP263 Laparoscopic surgery improves short- and medium-term outcomes of nerve-sparing radical hysterectomy: a propensity-matched analysis with open abdominal procedures Giorgio Bogani
EP264 Cervical cancer starring in the love story of brachytherapy planning techniques in an alluring tertiary cancer center Eduard-Alexandru Bonci
EP265 The role of methylation silencing of tumor suppressor genes in cervical HSIL: a prospective cytologic-histologic correlation study of 70 cases Jiri Bouda
EP266 Cervical Cancer in Pregnancy - a clinical case Rute Branco
EP267 Synchronous Primary Cervical and Fallopian Tube Carcinoma: A Case Report Cecilia Cabanag
EP268 Primary Pelvic Exenteration for Advanced Stages of Pelvic Cancers Mihai Emil Capilna
EP269 Correlation between the level of education and the adequacy of cervical excisional procedures in patients with cervical preinvasive lesions. Yasemin Ceylan
EP272 Prognostic value of lymph node characteristics in patients with node-positive or node-negative early-stage cervical cancer Gun Oh Chong
EP275 Cervical Cancer screening in Africa: a proposal of a different combination of VIA test and PAP smear in Uganda Giacomo Corrado
EP276 Toxicity evaluation of locally advanced cervical cancer David da Silva Dias
EP277 Special considerations in Quality of life of locally advanced cervical cancer patients David da Silva Dias
EP278 Atypical presentation of cardiac metastasis in uterine cervical cancer David da Silva Dias
EP279 A cohort retrospective study of the high-risk HPV recurrence in Greek women after cervical lesion treatment through detection of viral E6/E7 mRNA expression Angelos Daniilidis
EP280 Role of ganglioside GM1 expression in T lymphocytes membranes in cervical cancer development Damir Danolic
EP281 Observational study of the BGOG on the results of robot-assisted radical hysterectomy for stage I cervical cancer in Belgium. Anouk de Bruyn
EP282 Survival Analysis of Stage IB to IIA2 Cervical Cancer: A Five Year Single Institution Review Zelda Sue De Leon
EP283 Evaluation of quality of life in the patients with infiltrative cervical cancer by improving radical hysterectomy via using nerve-sparing method Tetyana Dermenzhy
EP284 Pulsed dose rate brachytherapy in gynecological cancers examples of cervical and endometrial cancer: experience of the radiotherapy service of Martinique Kadiatou Diakité
EP285 The impact of socioeconomic deprivation on survival in cervical cancer patients - a systematic review Hannah Donkers
EP286 Médecins Sans Frontière's cervical cancer project in Malawi: a collaborative and comprehensive strategy against cervical cancer Pierre-François Dupré
EP287 Iliopsoas Muscle Metastasis from Cervical Carcinoma Marjaneh Farazestanian
EP288 Prospective intra/inter-observer evaluation of pre-brachytherapy cervical cancer tumor width measured in TRUS and MR imaging Mario Federico
EP289 Evolving radiotherapy strategies to treat very advanced (FIGO IIIB/IV) cervical cancers Mario Federico
EP290 Epidermal and endothelial growth factors are associated with growth pattern of squamous cell carcinoma of the cervix Elena Frantsiyants
EP291 Surgery for early cervical cancer: a 10-year retrospective outcome comparison between laparoscopic and open radical hysterectomy in an Irish Centre. Enya Fullston
EP292 Difficulties in the diagnosis of premalignant changes in menopausal women Anita Ganovska
EP293 Advanced squamous cell carcinoma of uterine cervix with metastases- unpredicted long survival obtained after stereotactic radiation directed to the lung metastases Marzena Gawkowska
EP294 Comparison of triage management between p16INK4a/Ki67 dual staining and HR-HP test in patients with cervical cytology ASC-US and LSIL Li Geng
EP295 Investigating the Effect of Hypercapnia, Hypoxia and pH on Cellular Proliferation in Cervical Cancer Lucy Gentles
EP296 Vaginal Fertility-Sparing Surgery and laparoscopic sentinel lymph node detection in early cervical cancer. Oncological outcomes and long-term follow-up Blanca Gil-Ibañez
EP297 Different techniques for sentinel lymph node detection in early cervical cancer: one-center experience Ariel Glickman
EP298 Nerve-sparing versus non-nerve-sparing radical hysterectomy: surgical and long-term oncological outcomes Natalia R Gómez-Hidalgo
EP299 The impact of surgical approach on cervical cancer survival rates Myriam Gracia Segovia
EP300 Minimally invasive versus open-way surgery in early stage Cervical Cancer: SENTICOL I and SENTICOL II three years follow up. Benedetta Guani
EP301 Free radical processes in the blood of patients with cervical cancer receiving various postoperative treatment modalities M Gusareva
EP302 Low-dose ionizing radiation activates antioxidative defense system and immunological reactivity in patients with cervical cancer M Gusareva
EP303 Combination treatment of radiation injuries of the rectum in patients with pelvic tumors Marina Gusareva
EP304 Prevalence of preinvasive lesions in HPV 16/18 positive cases and HPV other positive with cytology negative cases in our region Kadir Güzin
EP305 Title : Rhabdomyosarcoma (RMS) of the uterine collar by the way of a case Authors : F.HADJARAB1 , CE CHEKMAN 2 , A.TAIBI 1 , K.BOUZID 1 1: Medical Oncology , CENTER PIERRE MARIE CURIE ALGIERS ALGERIA 2: Surgery Fatiha Hadjarab
EP306 Is ultrasound KUB a useful investigation following Radical Hysterectomy? Ashleigh Haken
EP307 The role and optimal regimen of radiation therapy for patients with bone metastasis from uterine cervical cancer Masaharu Hata
EP308 Postoperative morbidity of radical hysterectomy and pelvic lymphadenectomy in cervical cancer Maria Hernandez Ontoria
EP309 Survival analysis in advanced cervical cancer Maria Hernandez Ontoria
EP310 Incongruous pathological and radiological response in a case of a mucin secreting adenocarcinoma of the cervix Shaymaa Hosni
EP311 A single centre retrospective review of all patients treated for cervical cancer with high dose rate brachytherapy at Nottingham University Hospital NHS Trust Shaymaa Hosni
EP312 Laparoscopic radical hysterectomy has higher risk of perioperative urologic complication than abdominal radical hysterectomy: a meta-analysis of 38 studies Jong Ha Hwang
EP313 Additional chemotherapy after six cycles in stable disease of cervical cancer Woo Yeon Hwang
EP314 Management of cervical intraepithelial neoplasia 2 in young women Woo Yeon Hwang
EP315 Adenocarcinoma versus squamous cell carcinoma of cervix: Are we fighting two different beasts with same weapon? Mohammad Rafiqul Islam
EP316 Cervical pre-cancer screen and treat program using visual inspection by acetic acid and thermo-coagulation in Malawi Momoko Iwamoto
EP317 Efficacy of salvage hysterectomy following radiotherapy for uterine cervical adenocarcinoma Haruko Iwase
EP318 Laparoscopically assisted vaginal hysterectomy: best surgical approach in patients with endometrial/cervical cancer? Marika Japaridze
EP319 Gastric type endocervical adenocarcinoma without delay in diagnosis : uncommon and difficult to diagnosis by screening test Hyeji Jeon
EP320 Laparoscopic radical hysterectomy versus open radical hysterectomy in early stage cervical cancer; long term recurrence rates in the South East Wales Gynaecology Oncology Centre. Sadie Jones
EP321 Potential therapeutic candidate of cold atmospheric plasma for cervical cancer Min Hyung Jung
EP322 The influence of modulated electrohyperthermia (mEHT) on tumor cell apoptosis in iib−iva cervical cancer patients with deep parametrial invasion Madina Kaskulova
EP323 Extended nerve-sparing radical hysterectomy Tomoyasu Kato
EP324 MRI-based tumor volume evaluation at the time of brachytherapy as a predictor of survival in cervical cancer patients treated with definitive chemoradiation Clement Khoury
EP326 Overexpression of SOCS-1 may inhibit invasion and metastasis of cervical cancer Moon Hong Kim
EP327 No difference in overall survival rate between abdominal and minimally invasive radical hysterectomy for early cervical cancer: single institute, retrospective study for more than 10 years Sang Il Kim
EP328 Oncological outcomes and recurrent risk factors following laparoscopic radical trachelectomy with vaginal colpotomy in early stage cervical cancer Yong-Man Kim
EP329 Real World Experience of Pembrolizumab in Advanced or Recurrent Cervical Cancer Seong Hee Kim
EP330 Impact of preexisting bladder outlet obstruction on voiding dysfunction after radical hysterectomy for cervical cancer Taehun Kim
EP331 Clinical impact of boost irradiation to pelvic lymph node in uterine cervical cancer treated with definitive chemoradiotherapy Yeon Sil Kim
EP332 Laparoscopic radical hysterectomy in cervical cancer: Is peritoneal contamination with tumor cells an underestimated event? Rüdiger Klapdor
EP333 Laparoscopic radical hysterectomy compared to laparotomy in patients with early-stage cervical cancer. Lukasz Klasa
EP334 SENTIX - Sentinel Lymph Nodes in Patients with Cervical Cancer: SLN detection and the false negative rate of SLN frozen section (CEEGOG-CX01; ENGOT-CX2; NCT02494063). R Kocian
EP335 HER3 protein expression is risk factors for postoperative recurrence in patients with adenocarcinoma and adenosquamous carcinoma of the cervix Yuki Kojima
EP336 Glassy cell carcinoma of the uterine cervix. A rare and aggressive entity. Nektarios Koufopoulos
EP337 The philosophy of setinel lymph node in the management of early stage cervical cancer. Feasible or not? Ioanna Koutroumpa
EP338 Cervical cancer and vaginal flora changes Stefan Kovachev
EP339 Urologic complications of cervical cancer radical surgery Stefan Kovachev
EP340 Clinicopathologic Review of the Gastric-type Mucinous Adenocarcinomas of the Cervix in a Tertiary Referral Centre in Singapore Michelle Kwek
EP341 Screening capacity and cost-effectiveness of the human papillomavirus test versus cervicography as an adjunctive test to Pap cytology to detect high-grade cervical dysplasia Seon-Kyung Lee
EP342 Cognitive computing system in cervical cancer IB to IIA: a multicenter retrospective analysis Kwang Beom Lee
EP343 Number of harvested lymph nodes is major risk factor of the postoperative lymphocele after pelvic lymphadenectomy in women with cervical cancer Ji Woo Lee
EP344 Development of nomograms for prediction of disease recurrence according to the surgical approach in patients with stage IB cervical cancer Hyo Pyo Lee
EP345 Human papillomavirus L1 capsid protein and HPV test as a biomarker for cervical intraepithelial neoplasia 2+ in women with persistent ASCUS /LSIL cervical cytology Yong Seok Lee
EP346 The prognostic value of hematologic parameters in cervical cancer patients receiving radiation therapy Seok Ho Lee
EP347 Preliminary results of primary cancer boost using intensity-modulated radiation therapy for locally advanced cervical cancer Xiangpan Li
EP348 Fertility-sparing treatment for IB1 cervical cancer with tumors ≥ 2 cm:An updated series with 142 patients. Jin Li
EP349 Treatment outcome for primary cervix large B-cell lymphoma: a clinical analysis of 37 cases Xiaojian Liu
EP350 Research of 20 years of Intraoperative Electron Radiotherapy for Cervical Carcinoma stage IIB Zi Liu
EP351 Prevalence of genital infection by the Human Papilloma Virus in the Female Population of Gran Canaria( Spain) Amina Lubrano Rosales
EP352 The clinical utility of MRI and CT-PET following radical treatment for cervical carcinoma Graham Macdonald
EP353 Fertility sparing surgery following neoadjuvant chemotherapy of cervical cancer figo stage IB2 - case report Aljosa Mandic
EP354 Are the cervical cytologic abnormalities, colposcopic and histologic findings reliable in pregnant women? Fatima Martinez Hernandez
EP355 A feasibility study of robotic radical hysterectomy in patients with T1b1/2a1, N0 cervical cancer Hiroko Matsumiya
EP356 Sentinel Lymph node vs. lymphadenectomy in patients with early-stage cervical cancer: A single-center experience Eduard Mension
EP357 Transarterial embolisation for the treatment of acute gynecological cancer bleeding Philipp Meyer-Wilmes
EP359 Prognostic and therapeutic value of pelvic lymphadenectomy in locally advanced cervical cancer Gonzalo Mezquita
EP360 Single-agent amrubicin therapy for recurrent small cell neuroendocrine cervical carcinoma Shinichiro Minobe
EP361 Evolving and validating tool for capacity building of the existing health services staff for VIA and VILI based cervical cancer screening Gauravi Ashish Mishra
EP362 Survival rate comparisons in open versus laparoscopic approach in early stage cervical cancer patients treated in Kielce cancer center: a single institution experience Marcin Misiek
EP363 The role of PET-CT in the new FIGO 2018 classification for cervical carcinoma Constantijne Mom
EP364 Prognostic value of ddPCR HPV in lymph nodes of early cervical cancer Rosa Montero Macías
EP365 Prognosis factors in patients with early cervical cancer Rosa Montero Macías
EP366 Cervical cancer associated with genital prolapse: a case report Lavinia Mosca
EP367 Prevalence of high-risk human papillomavirus by cobas 4800 HPV test and the pathologic findings in women with high risk HPV positive in Mashhad (north-east of Iran) Masomeh Motaghi
EP368 Prognostic value of KI6 biomarker in predict short time prognosis of Low grade cervical intraepithelial neoplasia in HPV negative and positive patient Leila Mousavi seresht
EP369 An evaluation of SMI and SWE utility in the identification of the uterine cervical lesion Takayoshi Nakamura
EP370 The efficacy of hysterectomy for local remnant or recurrent cervical cancer after radical radiotherapy Tadaharu Nakasone
EP371 Non-brachytherapy approach to treatment of locally advanced cervical cancer Vladimir Nosov
EP372 DoVIA and TeleDoVIA as a Documentation and Consultation Media in VIA Methods of Cervical Cancer Screening in Indonesia Laila Nuranna
EP373 Humanistic Burden Associated with Cervical Cancer: An Analysis of Patient-Reported Outcomes in the European Union Five (France, Germany, Italy, Spain, and United Kingdom) Chizoba Nwankwo
EP374 Humanistic and Economic Burden Associated with Cervical Cancer in Japan Chizoba Nwankwo
EP375 Abdominal Radical Histerectomy for Cervical Cancer: recurrence and disease-free survival in a portuguese oncologic center Catarina Albuquerque Oliveira
EP376 BRCA1 immunohistochemistry expression and survival in cervical cancer E Sun Paik
EP377 Total laparoscopic radical trachelectomy with uterine arteries preservation for stage IB2 cervical cancer Nabilah Panchbhaya
EP378 Prognostic importance of lymph node in early cervical cancer JungWoo Park
EP379 Prognosis-predicting model based on F-18 PET metabolic parameters in locally advanced cervical cancer patients treated with concurrent chemoradiotherapy: Multi-center retrospective study Chul-Min Park
EP380 Clinical outcomes and predictive factors for bladder or rectal invasive cervical cancer after Definitive radiotherapy Sunmin Park
EP381 The role of diagnostic laparoscopic in locally advanced cervical cancer staging in the bevacizumab era. Luigi Pedone Anchora
EP382 Regular follow up with cervical/vault cytology is of questionable value in patients treated for microinvasive cervical cancer. Andrew Phillips
EP383 Serum concentrations of s100-a11 and aif-1 are elevated in cervical cancer patients with lymphonode involvement Radovan Pilka
EP384 Laparoscopic radical hysterectomy with consequent transvaginal closure of vaginal cuff - results of a retrospective analysis of a prospective collected multicentre database Andrea Plaikner
EP385 A single-center retrospective analysis to evaluate the prognostic role of lymph node density in patients with lymph node positive cervical cancer Arkadius Polasik
EP386 Cervical cancer screening in PHC organization in Poland Artur Prusaczyk
EP387 The rate of HPV and smear positivity in the follow-up period of patients that underwent cervical excisional procedures. Yunus Emre Purut
EP388 Laparoscopic para-aortic lymph node staging in the care of advanced cervical cancer (IB3-IVA): Retroperitoneal or transperitoneal? Emilie Raimond
EP389 Does Laparoscopic Extra-Peritoneal Para-Aortic Node Dissection aid treatment of women with Locally Advanced Cervical Carcinoma? A 9 year review of one institution in Northern Ireland Kelly Reilly
EP390 Open Radical hysterectomy for early cancer cervix - 10 years' experience from a tertiary cancer centre Prabhakaran Nair Rema
EP391 Rheumatoid arthritis as a risk factor for cervical cancer in Brazil Leandro Resende
EP392 Abdominal Radical Trachelectomy as a fertility-sparing treatment for early-stage cervical cancer; A single institution experience Alexandros Rodolakis
EP393 Liquid Nitrogen cryotherapy (N2Cryo) for Cervical intraepithelial neoplasia (CIN) Satoru Sagae
EP394 The importance of p16Ki-67 in cervical precancerous lesions Bugra Sahin
EP395 The Patient Had Stage IIIB Cervical Carcinoma With Pregnancy Has Followed Up Without Disease For 22 Years : Case Report Merve Sahin
EP396 Five-year survival and prognostic factors in women treated for cervix cancer at a tertiary care center Khalid Sait
EP397 Clinical contribution of antecedent ligation of uterine vessels in radical hysterectomy to the prognosis of patients with uterine cervical cancer Fumitaka Saito
EP398 Nerve-sparing radical hysterectomy: a standardized method for precision surgery and local control in cervical cancer Noriaki Sakuragi
EP399 Adenoid basal carcinoma combined with invasive squamous cell carcinoma of uterine cervix: a case report of a 37-year-old woman Suleyman Salman
EP400 Feasibility of FDG-PET-MRI during chemo-radiotherapy for cervical cancer Asma Sarwar
EP401 Ureter delineation and dose reporting in image guided brachytherapy for cervical cancer Asma Sarwar
EP402 Low Risk HPV types in CIN 2-3 and in Invasive Cervical Cancer patients Yakir Segev
EP403 Protein overexpression of c-MET has a significant impact on survival in patients with uterine cervical adenocarcinoma Shinhee Seo
EP404 Laparoscopic radical Trachelectomy with pelvic sentinel node dissection and cervical cerclage of a young woman with cervical cancer wishing to preserve Fertility -Case Report Panagiotis Sklavounos
EP405 Neuroendocrine carcinoma of the cervix (NECC)- case reports Magdalena Śliwińska
EP406 A year after: lessons learned from Laparoscopic Approach to Cervical Cancer (LACC) trial Marcin Śniadecki
EP407 Learning curve could affect the surgical outcome of radical hysterectomy in cervical cancer Jae Yun Song
EP408 Usefulness of evaluating lymphatic and venous vessel invasion separately in postoperative cervical adenocarcinoma Yusuke Taira
EP409 Colposcopy findings and biopsy results in HPV tested ASCUS patients Ozguc Takmaz
EP410 Reduced response to controlled ovarian stimulation after radical trachelectomy Satoshi Tamauchi
EP411 The evaluation of recurrence in vagina after surgery in gynecological cancer after surgery and compare surgery alone to surgery and radiotherapy Ewa Telka
EP412 Fertility sparing surgery of >2cm cervical cancer following neo-adjuvant chemotherapy: a 12-year experience in a single tertiary care center Freweini Tesfai
EP413 Definitive radiotherapy with low cumulative doses for uterine cervical cancer: a Japanese prospective study with no midline block Takafumi Toita
EP416 Large conization; an effective surgical approach for fertility preservation in young women with early stage cervical cancer Christos Tsaousidis
EP417 Trends in the incidence of carcinoma in situ and cervical cancer in Ukraine Nataliya Tsip
EP418 Immune checkpoint inhibitors in treating stage IV/recurrent cervical cancer and endometrial cancer Hsiu-Jung Tung
EP419 Efficiency of Sentinel Lymph Node Detection with Indocyanine Green in patients with Early Stage of Cervical Cancer. Single-Institutional Experience, n=80 Elena Ulrikh
EP420 The clinical outcomes of neoadjuvant dose-dense platinum-based chemotherapy in patients with locally-advanced cervical cancer (IB2-IIB FIGO stage). Elena Ulrikh
EP421 The experience of the N.N. Petrov National Research Center of Oncology in performing radical trachelectomy Adel Urmancheeva
EP422 After LACC Trial. A single institutional study with our own data. Jesus Utrilla-Layna
EP423 Case report of gastric type of invasive adenocarcinoma of the endocervix Valerie Uvin
EP424 Validation of the new FIGO 2018 staging system in clinically early cervical cancer. Jacobus van der Velden
EP425 Acute and long-term toxicity in patients undergoing induction chemotherapy followed by radiotherapy and hyperthermia for advanced cervical cancer Helena C. van Doorn
EP426 Predictive value of the sentinel lymph node biopsy (SLNB) in early-stage cervical cancer: is pelvic lymphadenectomy replaceable? Alicia Vazquez Sarandeses
EP427 Comparison of survival curves according to pronostic risk fatcors in patients with early-stage cervical cancer (ESCC) Alicia Vazquez Sarandeses
EP428 Risk of involvement of sentinel lymph nodes in cervical cancer stage IA1 with lymphovascular space invasion and and IA2 Monika Vetrovska
EP429 Laparoscopic management of urinary tract injuries during laparoscopic radical hysterectomy for cervical cancer Alla Vinnytska
EP430 Combination of FDG-PET metabolic parameters of Cervical tumor and pelvic lymph nodes predict paraaortic lymph node involvement in locally advanced cervix cancer. Marie Voglimacci
EP431 15-year survival and toxicity of locally advanced cervical cancer treatment with hyperthermia in combination with radiochemotherapy Ying Wang
EP432 HPV 18 predicts worse prognosis in patients with cervical cancer treated with chemoradiotherapy Ying Wang
EP433 The efficacy of adjuvant chemotherapy following radical hysterectomy for intermediate risk stage IB-IIA cervical cancer Yingwen Wang
EP434 Survival of patients with early-stage cervical cancer after abdominal or laparoscopic radical hysterectomy in the Netherlands Hans Wenzel
EP435 Characteristics of cervical cancer in Southwestern China and the clinical significance in young patients Lingyun Yang
EP436 The kinetic profile and clinical implication of SCC-Ag in squamous cervical cancer patients undergoing radical hysterectomy using Simoa assay: a prospective observational study Shuang Ye
EP437 Dosimetric analysis of 3D-printed minimally invasive-guided template in the combined intracavitary/interstitial brachytherapy treatment of locally advanced cervical cancer Xiangkun Yuan
EP438 Evaluation of cervical length and optimal timing for pregnancy after cervical conization in patients with cervical intraepithelial neoplasia Xiao Zhang
EP439 Predictive value of preoperative serum squamous cell carcinoma antigen (SCC-Ag) level on tumor recurrence in cervical squamous cell carcinoma patients treated with radical surgery: A Single-Institution Study Jun Zhu
EP440 Pembrolizumab Efficacy and Recurrence Pattern of Persistent and Metastatic Cervical Cancer. Jun Zhu
EP441 Synchronous small cell neuroendocrine carcinoma and adenocarcinoma in situ of the cervix Gojko Zovko
EP442 Laparoscopic nerve sparing Radical Hysterectomy without Uterine Manipulator in patients with cervical cancer. Dimitrios Zygouris
EP443 Laparoscopic nerve sparing Radical Hysterectomy for locally advanced cervical cancer, technique and follow - up data. Dimitrios Zygouris
EP444 Endogenous intoxication as a symptom of advanced gynecological cancer Meri Adamyan
EP445 The ADNEX model to triage adnexal masses: an external validation study and comparison with the IOTA two-step strategy and subjective assessment by an experienced ultrasound operator. Cinzia Baima Poma
EP446 When can we suspect gynecological lymphomas? Ultrasound features of ovarian and uterine lymphomas, a single-center experience. Safia Boussedra
EP447 Clinical and ultrasound features of extra gastrointestinal stromal tumors (eGIST) Daniela Fischerova
EP448 New diagnositc device for cervical dysplasia using electrical impedence imaging Yuki Gen
EP449 Magnetic resonance diffusion-weighted imaging in diagnostics of primary fallopian tube carcinoma. Preliminary report. Laretta Grabowska-Derlatka
EP450 The use of Indocyanine Green in gynae-oncology, beyond sentinel pelvic lymph nodes Michael Graham
EP451 Significance of CA-125 Levels in Uterine Papillary Serous Cancer Esra Keleş
EP452 Ultrasound diagnosis of ovarian tumours by pattern recognition Jure Knez
EP453 Fibrothecomas Masquerading as Ovarian Malignancy; A Review of Pre-Operative Imaging Desiree Kolomainen
EP454 Identification of miRNAs Associated with Endometriosis in Pakistani Women Irfana Liaqat
EP455 Diagnostic hysterectomy for clinical suspicion of uterine cancer when histological confirmation is either not possible or inconsistent with clinical findings Sofia Makrydima
EP456 Searching HPV genome for methylation sites involved in molecular progression to cervical precancer Vasilios Pergialiotis
EP457 Assessment of ovarian tumors with tumor educated platelets (TEPs) Jurgen M.J. Piek
EP458 Does HPV type affect the rate of positive surgical margin after cervical cone excision? Yunus Emre Purut
EP459 Clinical management of Ovarian Masses in Pregnancy Lorena Quagliozzi
EP460 Uncommon case of fallopian tubes teratocarcinomas in 36-year-old female. Karolina Rasoul-Pelińska
EP461 The role of certain morphological and doppler velocimetric ultrasonographic criteria in the prediction of adnexal mass malignancy Mile Tanturovski
EP462 Value of tumor markers and pelvic mass diameter in differential diagnosis of peritoneal carcinomatosis Carmen Tauste Rubio
EP463 Endometrial cancer recurrence in low risk patients - analysis of potential adverse risk factors in the experience of a single center Anna Abacjew-Chmylko
EP464 Relation between Human Epididymis Protein 4 (HE4) and endometrial pathology in patients with postmenopausal bleeding Ahmed Aboulnasr
EP465 Influence of infection in endometrial carcinoma on clinical and morphological characteristics of endometrial cancer Meri Adamyan
EP466 Stage II/III endometrial cancer - how RADICAL should we be? A review of management in the Northern Ireland regional cancer centre Susan Addley
EP467 Endometrial carcinoma in patients with sentinel lymph node biopsy: recurrences. Irati Aizpuru
EP468 Tumor size as prognostic factor of lymph node involvement in endometrial cancer Diana Al-Dali
EP469 Sentınel lymph node biopsy in early stage endometrial cancer: a Turkısh Gynecologıc Oncology Group study (TRSGO-SLN-001) Duygu Altın
EP470 Accuracy of ultrasound evaluation of endometrial cancer for assessing myometrial invasion and cervical stromal involvement. Rosa Maria Alvarez Lopez
EP471 Molecular Analysis of p53 codon 72 Polymorphism among women with Endometrial Cancer in Morocco: A Case-Control Study Bouziyane Amal
EP472 ErbB receptors profile in non-selected patients with endometrial cancer Georgios Androutsopoulos
EP473 ErbB receptors profiling in selected patients with type II endometrial cancer Georgios Androutsopoulos
EP474 The prognostic value of preoperative serum CA125 in endometrioid endometrial cancer with cervical stromal and parametrial invasion Atieh Bahman
EP475 Immunohistochemical expression of LHRH receptor in different anatomical compartments of endometrial cancer patients Bartłomiej Barczynski
EP476 Diagnostic value of Office endometrial sampling in postmenopausal bleeding Fariba Behnamfar
EP477 Laparoscopic versus abdominal surgery for 70-years and older women with endometrial cancer. Igor Berlev
EP478 Role of sentinel lymph node mapping with indocyanine green in patients with endometrial cancer. Single-institution experience, n=100. Igor Berlev
EP479 Agreement between magnetic resonance imaging, transvaginal ultrasound scan and intraoperative biopsy for determining miometrial infiltration in endometrial carcinoma. Tertiary centre results. Rocío Bermejo Martínez
EP480 The impact of gene-specific germline pathogenic variants on clinical presentation of endometrial cancer in Lynch syndrome Giorgio Bogani
EP481 Sentinel node mapping vs. lymphadenectomy in endometrial cancer: a systematic review and meta-analysis Giorgio Bogani
EP482 Associations between thrombocytosis, predictive biomarkers, and survival outcomes in uterine serous carcinoma Parker Bussies
EP483 Biomarker prediction of outcome varies by race in uterine serous carcinoma Parker Bussies
EP484 Warm ischaemia is an important pre-analytical variable affecting the analysis of endometrial biospecimens Lucy Button
EP485 Confounding Factors of trans-vaginal ultrasonography accuracy in endometrial cancer Vito Andrea Capozzi
EP486 Brain metastases from endometrial cancer: a case report Liliana Castro Oliveira
EP487 Panoramic view of endometrioid endometrial cancer in Turkey: a retrospective, multicenter study of Turkish Society of Gynecologic Oncology (TRSGO-END002) Engin Çelik
EP488 Is chemotherapy better for early stage high risk histologic types of endometrial cancer Engin Çelik
EP489 The outcomes of 146 women with surgically staged endometrioid endometrial cancer(EEC): A five years experience from Tata Medical Center , Kolkata Basumita Chakraborti
EP490 A Comparative Study between Laparoscopic and Laparotomy Approach for Surgical Staging in Early Stage Endometrial Cancer in Rajavithi Hospital, Thailand. Saranya Chanpanitkitchot
EP491 Retrospective review of sentinel lymph node mapping in endometrial cancer using indocyanine green and near infra-red fluorescence imaging during minimally invasive surgery- Mater Hospital experience Woraphot Chaowawanit
EP492 Comparison between laparoscopic and robotic surgery, for sentinel lymph node mapping in endometrial cancer using indocyanine green and near infra-red fluorescence imaging. Woraphot Chaowawanit
EP493 Does ultra-staging with immunohistochemistry improve the detection of metastasis in sentinel lymph nodes in endometrial cancer? Woraphot Chaowawanit
EP494 Expression of genes responsible for estrogen metabolism and reception in endometrial cancer depends on tumor grade Natalia Chernikova
EP495 Influence of comorbid estrogen-dependent uterine pathology on morphological characteristics of endometrial carcinoma Natalia Chernikova
EP496 Characteristics of patients with uterine sarcoma depending on morphological tumor structure, methods and results of treatment Natalia Chernikova
EP497 Adjuvant/radical radiotherapy in elderly women with endometrial cancer: is it justified based on survival outcomes? Marina Chitoni
EP498 Oncologic and pregnancy outcomes with fertility-sparing management for early endometrial cancer in young women Young Shin Chung
EP499 Volumetric-modulated arc therapy for adjuvant treatment of endometrial cancer Simona Cima
EP500 The diagnostic and prognostic value of serum L1CAM levels in endometrial cancer Aydın Çorakçı
EP501 Management of patients with metastatic endometrial cancer at diagnosis: single center experience Abel Cordoba
EP502 Blocking 17b-hydroxysteroid dehydrogenase type 1 in endometrial cancer: a potential novel endocrine therapeutic approach Karlijn Maria Cornelia Cornel
EP503 Real world outcomes of advanced endometrial cancer treated with neoadjuvant chemotherapy Cicely Cunningham
EP504 The role of the CA125 marker as a prognostic factor in endometrial cancer Aneta Cymbaluk-Płoska
EP505 A rare case of squamous carcinoma of the uterine body Cristina del Valle Rubido
EP506 The Role of Lymphovascular Space Invasion to Define Risk Groups of Endometrial Cancer Fuat Demirkiran
EP507 Has the Robot been beneficial to endometrial cancer patients? A prospective quality improvement project at a London Gynae-Oncology tertiary Centre Ayse Melin Dokmeci
EP508 Could microsatellite instability predict the response to immunotherapy in high-grade endometrial carcinomas? Triada Doulgeraki
EP509 Case series of uterine sarcomas associated with preoperative treatment with ulipristal acetate for supposed symptomatic myomas Andraž Dovnik
EP510 Robotic surgery: Does High Body Mass Index (BMI) matter? Stephania Drymiotou
EP511 Consistency Between Preoperative, Intraoperative, and Final Surgical Pathology in Endometrial Cancer Fatma Aslihan Dumlu
EP513 Intra-operative pelvic sentinel lymph node examination by imprint cytology in endometrial cancer. Ahmed Elagwany
EP515 Fertility-sparing hysteroscopic resection of the endometrium for patients with stage IA endometroid endometrial cancer: Farghaly´s technique Samir Farghaly
EP516 Single port access (SPA) robot assisted sentinel lymph node (SNL) mapping utilizing indocyanine green (ICG) for patients with stage I endometrial cancer: Farghaly's technique Samir Farghaly
EP517 Cost-effective improvement in endometrial cancer diagnosis by the incorporation of molecular analysis. Prospective pilot study. Sergi Fernandez-Gonzalez
EP518 'Sandwich' adjuvant chemotherapy and radiotherapy in high risk endometrial cancer: two institution experience Annamaria Ferrero
EP519 Cutaneous and muscular metastasis of an endometrial adenocarcinoma: a case report Yasmine Fertani
EP520 Comparison of different preoperative biopsy techniques in endometrial cancer Sara Forte
EP521 Treatment of peritoneal metastases from endometrial cancer with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, a systematic review of the literature. Alexandros Fotiou
EP522 Changes in transcriptional activity of apoptosis-regulating genes associated with age and endometrial cancer grade Elena Frantsiyants
EP523 Preliminary assessing the indication of MPA therapy for early endometrial cancer in the pregnancy point of view Tatsuro Furui
EP524 The significance of positive peritoneal cytology in G1/G2 endometrioid carcinoma of uterine body Seigi Furukawa
EP525 The role of LVSI to define the best adjuvant treatment in endometrial cancer (EC) Luca Fuso
EP526 Inactivating mutations of the IK gene inhibit endometrial cancer progression through regulating mitosis and non-homologous end joining DNA repair pathway Chao Gao
EP527 Low volume lymph node metastasis discovered by sentinel lymph node evaluation in endometrial cancer: Adjuvant and prognostic implication Virginia García Pineda
EP530 Indocyanine green in surgical staging of early stage endometrial cancer Igor Gladchuk
EP531 The presentation, treatment and clinical outcome of patients with dedifferentiated endometrial adenocarcinoma in singapore Charissa Goh
EP532 A rare case of uterine body metastasis from cecal adenocarcinoma. Christina Goudeli
EP533 The impact of morbid obesity on overall survival of the endometrial cancer Ahmet Baris Guzel
EP534 Left Parametrial invasion including distal ureter in endometrioid adenocancer Kadir Güzin
EP535 Analysis of endometrial cancer cases seen in a tertiary referral hospital Kadir Güzin
EP536 Obesity and Gynaecological Oncology Surgery in Wales: Rising to the challenge of an expanding population Ashleigh Haken
EP537 Dyskerin plays a negative role in endometrial epithelial cell proliferation and is associated with poor survival in endometrial cancer Dharani Hapangama
EP538 Prediction of pelvic lymph node metastasis in endometrioid endometrial carcinoma Atthapon Jaishuen
EP539 Treatment outcomes of serous carcinoma of endometrium: experience from a tertiary cancer center in Eastern India Dweep Jindal
EP540 Pathological factors associated with adverse outcomes in early stage Endometrial carcinoma. Dweep Jindal
EP541 Nationwide introduction of robotic minimally invasive surgery was associated with improved survival and decreased odds of severe complications in women with early-stage endometrial cancer —a population-based prospective cohort study Siv Joergensen
EP542 Computer adaptive testing discriminates early recovery after robotic surgery in women with early-stage endometrial cancer Siv Lykke Jørgensen
EP543 Safety of ovarian preservation in premenopausal women with endometrioid endometrial cancer clinically confined to the uterus U Chul Ju
EP544 Saten III- Splitting Adjuvant Treatment into subgroups of stage III endometrioid Endometrial cancers: An international, multicenter study Ilker Kahramanoglu
EP545 Imaging-based definition of lower uterine segment carcinoma to improve the detection sensitivity of probable Lynch syndrome Hidenori Kato
EP546 Laparoscopy should be the preferable route in the morbidly obese endometrial cancer Ghanim Khatib
EP547 Clinicopathologic significance of mismatch repair protein expression in endometrial cancer Mi-Kyung Kim
EP548 Clinicopathologic characteristics and treatment outcomes of Endometrial stromal sarcoma Mi-Kyung Kim
EP549 Clinical implication of preoperative tumor grade results in endometrial cancer with low-risk for lymph node metastasis Miseon Kim
EP550 Prognosis trend of grade 2 endometrioid endometrial carcinoma: toward grade 1 or 3? Umran Kucukgoz Gulec
EP551 A Clinicopathologic Characteristics and Prognosis Comparison Between Uterine Carcinosarcomas and Uterine High Grade Endometrial Carcinomas Umran Kucukgoz Gulec
EP552 Comparison of robotic versus laparoscopic surgery for endometrial cancer staging: our institution's experience Minsun Kyung
EP553 An unusual presentation of endometrial cancer with bilateral adrenal metastases at the time of diagnosis Alexandros Laios
EP554 The effects of Cimicifuga racemosa extract on endometrial and ovarian cancer cell lines Tea Lanišnik Rižner
EP555 Biomarkers for Diagnosis and Prognosis of Endometrial Carcinoma: BioEndoCar Tea Lanišnik Rižner
EP556 Decreased s-Tie2 plasma concentration in patients with endometrioid endometrial cancer Tea Lanišnik Rižner
EP557 Efficacy and Survival Outcomes of Minimally Invasive versus Open Pelvic and Para-aortic Lymphadenectomy in Early Stage Endometrial Cancer Ho Sze Jacqueline Lee
EP558 Favorable factors of surgical resection for recurrent uterine leiomyosarcoma Eun Ji Lee
EP559 Pelvic vs. para-aortic lymphadenectomy for patients with type I endometrial cancer: a comparison of outcomes Lin Li
EP560 Rare pathology of a malignant uterine myxoid leiomyosarcoma with osteocartilaginous differentiation Yu Hui Lim
EP561 The effect of combined progesterone and GnRH agonist on the growth of endometrial cancer cells Soyi Lim
EP562 Incidence of Isolated Tumor Cells after Sentinel Lymph Node ultrastaging in early stage Endometrial Cancer Valentina Locati
EP563 Mismatch repair deficiency glands in normal endometrial tissue as a predictor of endometrial carcinoma in patients with Lynch syndrome Pien Lof
EP564 Sentinel lymph node biopsy using indigocyanine green fluorescence in uterine cancer Gian-Luzi Looser
EP565 Diagnostic performance of transvaginal ultrasonography in the preoperative staging of endometrial cancer Amina Lubrano
EP566 Location of sentinel lymph nodes in endometrial cancer in a series of 207 patients with dual tracer injection in cervix and uterine fundus. Mikel Mancisidor
EP567 Low-volume disease, treatment and results in endometrial cancer Mikel Mancisidor Iztueta
EP568 Robotic paraaortic lymphadenectomy in oncogynecology. Double side docking of daVinci S system increases the success rates of high paraaortic lymph node dissection in endometrial cancer Radim Marek
EP569 Potential role of PAI-1 in endometrial cancer progression and its regulation by epigenetic mechanisms. Josep Marí-Alexandre
EP570 Obturator nerve section during laparoscopic pelvic lymphadenectomy, what to do? Carmen Martín Blanco
EP571 Sentinel node mapping in endometrial cancer: analysis of more than 200 cases of hysteroscopic injection of tracers. Fabio Martinelli
EP572 Analysis of the histological prognostic factors for survival to take into consideration in the management of the endometrial cancer Ester Martínez Lamela
EP573 The Expression of L1CAM and β-catenin in Endometrial Carcinoma Rina Masadah
EP574 Long term results of Endometrial cancer stage Ib G1-2 treatment Siarhey Mavrichev
EP575 Patterns of relapse in endometrial cancer Gemma McCormick
EP576 A novel multivariable prediction model for lymphatic dissemination in endometrioid endometrial cancer: The lymph node metastasis risk index Mehmet Mutlu Meydanli
EP577 Is it possible to develop a prediction model for lymphovascular space invasion in endometrioid endometrial cancer? Mehmet Mutlu Meydanli
EP578 Detection of lymph vessel invasion and blood vessel invasion using double D2-40 and CD31 immunohistochemistry reveals independent prognostic significance of blood vessel invasion in endometrial cancer Ani Mihaljević Ferari
EP580 Metformin may attenuate the effect of hyperprolactinemia induced by medroxyprogesterone acetate during fertility-sparing treatment for patients with atypical endometrial hyperplasia and endometrial cancer Akira Mitsuhashi
EP581 Tissue fibrinolysis and VEGF in tissues of uterine myoma combined with breast cancer Tatiana Moiseenko
EP582 Association between changes in relative expression of genetic loci encoding transcription factors and age and endometrial cancer grade Tatiana Moiseenko
EP583 Surgical management of the endometrial cancer and analysis of the surgical prognostic factors for disease recurrence and overall survival Jesús Molero Vílchez
EP584 Circulating tumour DNA to monitor tumour activity in endometrial cancer Esther Moss
EP585 Attitudes and barriers to window-of-opportunity trials in women who have undergone treatment for endometrial cancer. Esther Moss
EP586 Robotic Surgery and Perioperative Morbidity in very Elderly Women (≥75 years old) with type 2 endometrial cancer Eva Myriokefalitaki
EP587 Medroxyprogesterone acetate (MPA) maintenance therapy to treat recurrent endometrial cancer: case reports Hiroaki Nagano
EP588 Sentinel lymph node mapping with indocyanine green in laparotomy for endometrial cancer Zheng Yuan Ng
EP589 Modified radical hysterectomy reduce the recurrence of the vaginal stump in patients with early-staged endometrial cancer Akiho Nishimura
EP590 Is tumor free distance an independent prognostic factor for early stage endometrioid endometrial cancer? Tufan Oge
EP591 Survival and recurrence rates in stage II endometrial cancers in related to uterine-risk stratification after the introduction of lymph node resection and the omission of postoperative radiotherapy. A Danish gynecological cancer study group Gitte Ørtoft
EP592 HE4 has a role in identifying high risk prognostic factors in endometrial cancer. Sharon O'Toole
EP593 Clinicopathological features of endometrial carcinoma without abnormal uptake of 18F-fluorodeoxyglucose on pretreatment PET/CT Isao Otsuka
EP594 Recurrent Endometrial Adenocarcinoma with Pancreatic Metastasis Gonca Özten
EP595 SLN mapping for early endometrial cancer with concurrent two different tracers (radioactive and ICG); a pilot study. Maja Pakiž
EP597 The Complementary Role of serum CA19-9 in maliganat transformation of adenomyosis in endometrial cancer Seong Hye Park
EP598 Preliminary results of Immunohistochemical tumor markers evaluation in endometrial cancer patients. Michele Peiretti
EP600 Correlation between preoperative imaging biomarkers and histological prognostic factors in endometrial cancer: a prospective study. Giorgia Perniola
EP601 Pelvic and para-aortic versus pelvic lymphadenectomy in intermediate and high risk endometrial cancer: a systematic review and meta-analysis. Stamatos Petousis
EP602 The role of sentinel node assessment and laparoscopic approach in decreasing morbidity of staging surgery for endometrial cancer Robert Poka
EP603 Three types of sentinel lymph nodes and three routes of lymph drainage for endometrial cancer Olena Postupalenko
EP604 The emerging role of Microcystic, Elongated, Fragmented (MELF) pattern of myometrial invasion in the diagnostic pathway of endometrial cancer: a systematic review of the literature Anastasia Prodromidou
EP605 A single center study of the role of inflammation biomarkers in endometrial cancer. Anastasia Prodromidou
EP606 Concurrent panniculectomy at the time of gynaecologic surgery in obese women treated for gynaecologic cancer, a single center experience Victoria Psomiadou
EP607 Tumor markers and ultrasound findings in endometrial cancer: a single institution 5 year report. Victoria Psomiadou
EP608 Learning curve with ICG SLN mapping in endometrial cancer Alfonso Angel Quesada Lopez-Fe
EP609 The prognostic role of LRIG proteins in endometrial cancer Zoia Razumova
EP610 Investigation of patient acceptability of ctDNA in endometrial cancer follow-up Anna Relton
EP611 Microcytic elongated and fragmented (MELF) pattern in early-stage endometrioid adenocarcinoma - is there association with vaginal recurrence? - A case report Inês
EP612 Repair of external iliac arter with endovascular graft at a case of dedifferentiated endometrial carsinom Seda Şahin Aker
EP613 Prospective validation study on feasibility of Sentinel Lymph Node mapping in early endometrial cancer Suchetha Sambasivan
EP614 Prognostic implication of primary treatment of uterine low grade endometrial stromal sarcoma: An Institutional experience Suchetha Sambasivan
EP615 Implementation of enhanced recovery after surgery for endometrial carcinoma: a non-randomized controlled trial Ahmad Sameer
EP616 Risk factors for failure of sentinel lymph node mapping using indocyanine green/near‑infrared fluorescent imaging in endometrial cancer Mustafa Erkan Sarı
EP617 Second line treatment in metastatic uterine pecoma Apostolos Sarivalasis
EP618 The use of Preoperative Imaging in Endometrial Cancer: Are Ontario physicians following GOC guidelines? Kara Schnarr
EP619 Clinical Implications of molecular profiling in patients with primary endometrial cancer Richard Schwameis
EP620 Characterisation of the microbiome along the female genital tract and rectum in endometrial cancer Anita Semertzidou
EP621 Treatment results and patterns of failure of Type II endometrial cancer patients treated at radiotherapy department, national cancer institute, Cairo University, during the period from January 2000 till December 2012 Mohamed Serageldin Abdelaziz
EP622 Use of Pelvic lymphadenectomy in the management of high grade & Type 2 endometrial cancer: a survey of current practice of gynaecological oncology centres in the United Kingdom. Aarti Sharma
EP623 Sex hormonal profile during the development from endometrial hyperplastic disease to endometrial cancer Yue Shi
EP624 Non-endometrioid adenocarcinoma of the uterine corpus: clinicopathological results and treatment outcomes Mohamed Shouman
EP625 Laparoscopic transperitoneal para-aortic lymphadenectomy Panagiotis Sklavounos
EP627 Clinico-pathological Aspects of Vanishing Endometrial Cancer Sunamchok Srijaipracharoen
EP628 Recurrence rate after laparoscopic surgery versus laparotomy for early stage endometrial cancer Rok Sumak
EP629 Two young patients with endometrial cancer who newly developed double cancer in their ovaries after endometrial tumor disappearance through high-dose progesterone therapy and endometrial curettage. Nobuyuki Susumu
EP630 Assumption of responsability of the uterine sarcoma ,experiment of the service of medical oncology center Pierre and Marie Curie. (CPMC) Algiers , Algeria Authors : F.HADJARAB1 , CE CHEKMAN 2 , A.TAIBI 1 , K.BOUZID 1 1: Medical Oncology , CENTER PIERRE MARIE CURIE ALGIERS ALGERIA 2: Surgery Abdelmounaim Taibi
EP631 Expression of P-REX2a is associated with poor prognosis in endometrial malignancies Sho Takeshita
EP632 Does resection of normal appearing omentum influence survival in patients with type 2 endometrial carcinoma? Ori Tal
EP633 Hysteroscopic treatment of Uterine tumor resembling ovarian sex cord tumor (UTROSCT): A Case report Alon Tal
EP634 Comparison of robotic single-site (RSS) and robotic multiport (RM) total hysterectomy (TH) plus sentinel lymph node (SLN) mapping in low risk endometrial cancer (EC): quality of life (QoL) and surgical outcomes analysis. Saverio Tateo
EP635 Minimizing the dose of oral megestrol in combination with the Levonorgestrel-Releasing Intrauterine Device: an equally effective approach for the conservative management of Atypical Hyperplasia and well differentiated endometrial carcinoma Vasilios Theodoulidis
EP636 Assessing the impact of clinicopathological prognostic variables on survival outcome in patients with clear cell endometrial carcinoma: an institutional analysis. Nikolaos Thomakos
EP637 Are any pathologic variables of lymph node metastases reliable enough to predict survival in high grade endometrial cancer? Nikolaos Thomakos
EP638 Lynch syndrome-associated endometrial cancer with BRCA1 mutation. Irina Tripac
EP639 Treatment of elderly patients ( ≥ 70 years old) with endometrial cancer. Long-term outcome Adel Urmancheeva
EP641 Case report of low grade sarcoma of endometrial stroma with no primitive uterine site Valerie Uvin
EP642 Combined programmed cell death ligand 1 (PD-L1)/CD8 expression in grade 3 endometrial carcinomas Stylianos Vagios
EP643 Sentinel Node Detection Using Indocyanine Green in Intermediate Risk of Early Endometrial Carcinoma: Initial Experiences with the Robotic daVinci X System. Petr Valha
EP644 Trends over time in use of primary and adjuvant hormonal therapy for endometrial cancer: a population based study. Willem Jan van Weelden
EP645 Anti-estrogen treatment in endometrial cancer: a systematic review Willem Jan van Weelden
EP646 Could the long-term oncological safety of laparoscopic surgery in low risk endometrial cancer be also valid for the high intermediate and high-risk patients? A multi-center Turkish gynecologic oncology group study conducted with 2745 endometrial cancer cases Mehmet Ali Vardar
EP647 The Effect of Bariatric Surgery on Endometrial Cancer Dimitra Vasileiadou
EP648 Subungual metastasis of an endometrial carcinoma Anastasia Vernadou
EP649 Pattern of Recurrence in Patients with Endometrial Cancer Enrico Vizza
EP650 Ultrasound screening for endometrial abnormalities in patients on tamoxifen Boris Vranes
EP651 The predictive value of preoperative haematological parameters in relation with CA-125 in endometrial cancer Stephanie W. Vrede
EP652 Clinicopathological characterstics and survival analysis of Clear cell carcinoma endometrium: A single institution experience of tertiary cancer centre in India. Sunaina Wadhwa
EP653 Metabolic Surgery for Obese Patients with Early Stage Endometrial Cancer Michael Wilkinson
EP654 Adenosarcoma of the uterus with heterologous elements: Early recurrence of a case before first follow-up examination Ibrahim Yalcin
EP655 A feasibility study of sentinel lymph node surgery for laparoscopic approach in endometrial cancer Ryutaro Yamada
EP656 Post-transcriptional regulation of prognostic factor PD-L1 expression by 17β-estradiol via PI3K/Akt signaling pathway in endometroid cancer Lingyun Yang
EP657 The Risk Factors and Therapeutic Regimens Analyses in the Fertility-sparing Treatment of Refractory Endometrial Atypical Hyperplasia and Endometrial Cancer Bingyi Yang
EP658 Adjuvant locoregional chemo-irradiation followed by sequential chemotherapy for high risk endometrial cancer, single centre real-world experience Wing Ling Winnie Yip
EP659 Role of tumor grade on preoperative endometrial biopsy in predicting recurrence in endometrioid endometrial cancer Ji Geun Yoo
EP660 Novel approach to noninvasive assessment of lymph-nodes metastases with one-step isothermal quantification of mRNAs in primary tumor of endometrial cancer Emiko Yoshida
EP661 Sentinel node mapping with indocyanine green and endoscopic near-infrared fluorescence imaging in endometrial and cervical cancer: a systematic review to assess impact of technical aspects on detection rate and diagnostic performance Kamil Zalewski
EP662 Potential clinical value of Interlikin-31 and Interlukin-33 expressions as diagnostic and predictive factors in endometrial cancer: a case control study Xi Zeng
EP663 Correlation between adenomyosis and endometrial cancer: 6-year experience of a single center Dimitrios Zouzoulas
EP664 The effectiveness of the procedure of IVF in patients with uterine myoma Farida Ayupova
EP665 Juvenile granulosa cell tumors of the ovary: a retrospective study of 36 patients Morgane Blot-Dupin
EP666 Childbearing desire and pregnancy outcome in patients underwent fertility sparing surgery for Borderline Ovarian Tumours Giorgio Candotti
EP667 fertility preservation in breast cancer: the protective role of letrozole Nesrine Chraiet
EP668 Cancer in pregnancy: a 15-year descriptive analysis of 86 consecutive patients Eugenia Di Loreto
EP669 Fertility sparing surgery for borderline ovarian Brenner tumour: a literature review Giulia Garofalo
EP670 Oncofertility program in Poland - a single center experience. Robert Jach
EP671 Genital warts in pregnancy-diagnosis and treatement the most common cause of laryngeal paillomatosis in children under 10 years old Igor Jeremic
EP672 The effect of uterine myoma on the course and outcome of pregnancy in women with preeclampsia. Makhmuda Kattahodjaeva
EP673 Carcinoma sigma and pregnancy in 29 year old women; a case report Vesna Krsic
EP674 Fertility-sparing surgery for pediatric/adolescent patients with sarcoma involving the uterine cervix Jin Li
EP675 Pregnancy After Fertility Sparing Treatment of Embrional Carcinoma Figo III C Dženita Ljuca
EP676 Outcomes after conservative treatment of stade II and III serous borderline tumors of the ovary. Sophie Maria
EP677 The Asiaglycoprotein Receptor Expression in Placental of HbeAg positive Mother Could be Used as A Predictor of Hepatitis B Virus Transmission from Mother to Child Rina Masadah
EP678 Pregnancy and postpartum changes in uterine cervical biopsy abnormalities at our hospital Ayako Miura
EP679 Case report: Locally advanced rectal cancer in pregnancy Beatrice Mohelnikova-Duchonova
EP680 Impact of Pregnancy on the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers Michele Peiretti
EP681 Adult granulosa cell tumor associated with peritoneal endometriosis: Is it fair to preserve fertility? Leandro Resende
EP682 Laparoscopic Ovarian transposition in non-gynaecological cancers: more than just oncological outcomes TS Shylasree
EP683 Management of pregnancy after fertility-sparing surgery for cervical cancer Jiri Slama
EP684 Ovarian tissue cryopreservation during surgical treatment of patients with gynecological malignancies in Slovenian population Špela Smrkolj
EP685 Management of Acute Lymphoblastic Leukemia in a 26-year-old Primigravida Marianna Theodora
EP687 Cancer during pregnancy: Our experience of 16 cases. Dimitrios Tsolakidis
EP688 Perinatal outcomes of Hobnail-like shallow electrosurgical excision prosedure (HEEP) for the treatment of HSIL: prevention of IIOC Joo Hee Yooon
EP689 Cytoreduction and Hyperthermic intraperitoneal chemotherapy followed by Hyperthermic intraperitoneal chemotherapy (CRS+HIPEC) in advanced peritoneal carcinomatous (APC) at the American University of Beirut Medical Center (AUBMC) experience 2007-2018: A retrospective review Reem Abdallah
EP690 Pelvic exenteration for advanced gynaecological malignancy in South-West Wales Ganiy Opeyemi Abdulrahman Jnr
EP691 Does apronectomy improve outcomes for the morbidly obese patient undergoing gynae cancer surgery? A review of four cases Susan Addley
EP692 FUlvestrant in gynaecological Cancers that are potentially Hormone Sensitive: the FUCHSia Study Frédéric Amant
EP693 Disseminated peritoneal leiomiomatosis: Report of a case and review of literature Nathalia Ardila
EP694 The Role of Pulmonary Metastectomy in Gynaecology Malignancy. Fionnvola Armstrong
EP695 Uterine Arteriovenous Malformation after Molar Pregnancy: A Case Report and Review of Literature Noushin Babapour
EP696 Inoperable pelvic sidewall recurrence of gynecological cancer treated with proton and carbon ion radiotherapy: CNAO preliminary experience Amelia Barcellini
EP697 Establishing the Audit and Research in Gynaecological Oncology (ARGO) Collaborative in the United Kingdom and Ireland Rasiah Bharathan
EP698 Is chemotherapy induced alopecia an avoidable side effect in routine daily practice? Raffaella Bracci
EP700 Pelvic exenteration for recurrent gynaecological cancer- outcome of patients referred but not operated on Stacey Bryan
EP701 Risk of Clinically Overt Venous Thromboembolism in Post-Operation Gynaecological Cancer Patients - Data from a Hong Kong Tertiary Hospital Yu Ka Victoria Chai
EP702 Multiple primaries in gynecological cancer-a retrospective observational study from 1990-2017 in a tertiary cancer centre in Eastern India Bimankumar Chakrabarti
EP703 Comparison of mesonephric adenocarcinoma in the uterine corpus with that in the uterine cervix: A single-institution study of 12 cases Ji-Yeong Choi
EP704 Is SOFA score reliable in a Gynecologic Oncology setting or is something missing? A retrospective study on predictors and risk factors for bloodstream infections. Giacomo Corrado
EP705 The uterine mass Magna Graecia risk index in discriminating between benignant and suspicious malignant uterine masses Annalisa Di Cello
EP706 Impact of malignant gynecological disease on occurrence of surgical site infection Jelena Dotlic
EP707 Gonadal dysgenesis - a rare congenital hereditary defect Petr Dzvincuk
EP708 Multidisciplinary approach to management of fistulae in Gynaecological Oncology - 5 year experience Ahmed Farrag
EP709 Segmental ureteral resection with ureteroneocystostomy for gynecologic malignances: a case series Alex Federico
EP710 Retinal central vein occlusion with tamoxifen therapy : a case report Yasmine Fertani
EP711 Three Unexpected Cases of Gynecological B-cell Lymphoma Clarisse Salete Fontana
EP712 Ovarian borderline tumors with invasive peritoneal implants: A long term follow-up study of 30 patients. Leopold Gaichies
EP714 RaNGO: A study to collect accessible information about patients with Rare Neoplasms of Gynaecological Origin in the UK Marcia Hall
EP715 Identification and extirpation of local recurrences of gynecological cancer using ROLL technique. Sara Iacoponi
EP716 A systematic review and meta-analysis on the effect of extraperitoneal laparoscopic lymph node dissection in patients with gynecological malignancies Christos Iavazzo
EP717 Challenging diagnosis: plexiform tumorlet. A rare variant of uterine leiomyoma. Evaggelia Karopoulou
EP718 Uterine tumour resembling ovarian sex cord tumour (UTROSCT): a case report Evaggelia Karopoulou
EP719 Cervical squamous cell carcinoma in situ with superficial intraepithelial extension to the endometrium: A rare case Evaggelia Karopoulou
EP720 Endosalpingiosis and papillary serous carcinoma in inguinal lymph nodes with uninvolved adnexae: a case report Vasileios Kartsiounis
EP721 Obturator nerve injury in pelvic lymphadenectomy - to stitch or not to stitch? Peter Kaščák
EP722 A comparative analysis between unidirectional barbed versus conventional vicryl suture for vaginal cuff closure in cases of Total laparoscopic Hysterectomy Kavita Khoiwal
EP723 Importance and significance of fertility sparing surgery in borderline ovarian tumors. Seongmin Kim
EP724 Morcellation of uterine sarcoma might not be a risk factor for recurrence any more Yeni Kim
EP725 Lymphocyte-monocyte ratio predicts uterine sarcoma aggressiveness Hong Bae Kim
EP726 One-Step Nucleic Acid Amplification, are we witnessing a rise of a new method in nodal assessment? Jan Kostun
EP727 Presentation of the 14th case of Leiomyoadenomatoid tumor in the English literature. Nektarios Koufopoulos
EP728 Targeted radiotherapy improves progression free survival and delays time to systemic therapy in limited relapse of ovarian cancer Aswin Kumar
EP729 A rare form of ovarian serous cystadenoma with monodermal teratoma in a 53-year-old patient Antonios Lagkadas
EP730 Prevalence of germline BRCA mutations among women with carcinoma of the peritoneum or fallopian tube Chan Lee
EP731 Comparison of histological outcomes between pre-menopausal and post-menopausal women with report of cervical cytological abnormality Jeong Eun Lee
EP732 Bladder Endometriosis Mimicking Invasive Pelvic Malignancy Michelle Loh
EP733 Incidental finding of vulvar syringoma during the treatment of vulvar intraepithelial neoplasia - a case report Luka Marcelić
EP734 The value of omentectomy for surgical staging of borderline ovarian tumors Sophie Maria
EP735 Atypical Leiomyoma (AL) and smooth muscle tumors of uncertain potential (STUMP): a clinicopathological review on 9 cases Carmen Martín Blanco
EP736 Postoperative gastric perforation after cytoreductive surgery: an ischemic complication caused by spleen and omental resection Carlos Martínez-Gómez
EP737 Intraoperative Brachytherapy (HDR-IOBT) in advanced or recurrence gynecologic cancer: an effective alternative in tumors of poor prognosis. Juan Carlos Muruzábal Torquemada
EP738 Successful Management of Cervical Ectopic Pregnancy: A Case Report Maryam Nakhaee
EP739 Significance of Brain metastases in Gynaecological cancer patients Aiko Ogasawara
EP740 “Peritoneal inclusion cysts following ART. A rare case report.” Maria Oikonomou
EP741 100,000 Genome Project - the future of personalised medicine in gynaecological cancer management? Danielle O'Neill
EP742 Cancer genomic and personalized medicine for gynecologic tumors in our hospital Noriko Oshima
EP743 Abnormally High Levels Of Ca19-9 - A Mature Cystic Teratoma Case Report Gonca Özten
EP744 Assessing the impact of clinicopathologic features and recurrence patterns of Uterine Carcinosarcomas: an institutional analysis. Ioannis K. Papapanagiotou
EP745 Differences in autophagy-associated mRNAs in peritoneal fluid of patients with endometriosis and gynecologic cancers Dong Choon Park
EP746 Predictive factors for chemotherapy-induced nausea in patients with gynecological cancer Micaela Petrone
EP748 Laparoscopically guided TAP block for patients undergoing robotic assisted gynaecologic surgery - A prospective double blind Randomised trial to assess Analgesic efficacy Anupama Rajanbabu
EP749 A retrospective analysis of factors influencing the survival in patients with uterine Leiomyosarcoma Anupama Rajanbabu
EP750 Experience of setting up a Robotic Surgery program for women with gynae cancers at a tertiary level cancer center in eastern India Arunava Roy
EP751 Cancer in the elderly: do we treat them in the same way? Inês
EP752 Medical Treatment of Uterine Arteriovenous Malformations: A Case Report Shohreh Saied
EP753 Single centre experience with anti-PD1 therapy in gynaecologic cancers Apostolos Sarivalasis
EP754 Expression of OCT4, Sox2 / 3 self-renewal genes and Gankyrin oncogene in patients with ovarian cancer Norieh Sharifi
EP757 Relationship satisfaction mediates the association between emotional expressiveness and depressive symptoms among asian women Komal Tewani
EP758 Comparison of outcomes with ileal and colonic incontinent urinary conduits in and irish gynaecological oncology centre Claire Thompson
EP759 Does Bilateral Salpingo-Oophorectomy Influence Prognosis of Uterine Leiomyosarcoma Dominika Trojnarska
EP760 Vulvar sarcoma - rare malignancy with favorable prognosis in case of timely diagnosis and treatment Elena Ulrikh
EP761 Incidentally detected intravenous leiomyomatosis limited to uterus: a case report Esra Uyanık
EP762 Analysis of complications during and after laparoscopic lymphadenectomy by gynecologic malignancies. Jekaterina Vasiljeva
EP764 A prospective study of closed-incision negative pressure wound therapy following midline laparotomy in gynaecological oncology operations Lucia Yin
EP765 The Effect of MalforminA1 on Cisplatin-Sensitive and Cisplatin-Resistant Ovarian Cancer Cell Lines Nada Abdullah
EP766 Clinico-pathological features of ovarian granulosa cell tumours Ganiy Opeyemi Abdulrahman Jnr
EP767 A survey of germline mutations with epithelial ovarian cancer in Japanese patients Akiko Abe
EP768 Institutional results of OncoOVARIAN Dx - a novel algorithm for the management of adnexal masses Patriciu Achimas-Cadariu
EP769 Survival associated with first-line bevacizumab maintenance therapy among older patients with ovarian cancer: findings from the VIERA Study Gboyega Adeboyeje
EP770 Real-world Treatment Experience in Patients with Ovarian Cancer: Findings from a Retrospective Analysis of the SEER-Medicare Database in the United States Gboyega Adeboyeje
EP771 Could imaging predict lymph node invasion in advanced epithelial ovarian cancer ? Crestani Adrien
EP772 Testing for concordance of somatic and germline BRCA1/2 pathogenic mutations in Ovarian Cancer patients eligible for PARP inhibitors therapy: large single-site institution experience. Iolia Akaev
EP773 Splenectomy as primary cytoreductive surgery in advanced stage epithelial ovarian cancer Huseyin Akilli
EP774 Gallic acid exhibits lower cytotoxicity on normal ovarian cells than cisplatin-sensitive and cisplatin-resistant ovarian cancer cells Najwa Al Balushi
EP775 Differential Expression of SOCS2 gene and Its Putative Role in Ovarian Cancer Fatima Al Kindi
EP776 Müllerian Carcinoma in the rectovaginal septum. María Alonso Espías
EP778 The role of the E-cadherin/ β-catenin signal transduction pathway in the prognosis of advanced stage high-grade serous ovarian/fallopian tube cancer Igor Aluloski
EP779 Survival and prognostic factors in women treated for ovarian cancer in western region of Saudi Arabia Nisreen Anfinan
EP780 Prognostic Impact of Celiac Lymph Node Involvement in patients after Frontline Treatment for Advanced Ovarian Cancer Martina Aida Angeles
EP781 Predictive risk factors of acute kidney injury after cytoreductive surgery and cisplatin-based hyperthermic intraperitoneal chemotherapy for ovarian peritoneal carcinomatosis Martina Aida Angeles
EP782 Transition zones and progenitor cells in ovarian cancer pathogenesis Aleksandra Asaturova
EP783 Epithelial-mesenchymal tranzition and angiogenesis dialog in borderline ovarian tumors complicating pregnancy. Aleksandra Asaturova
EP784 Innovative diagnostic panel (p16, stathmin1 and laminin-gamma1) for ovarian cancer precursor detection Aleksandra Asaturova
EP785 Does Progression Free Survival(PFS), Overall Survival(OS) or platinum sensitive interval(PSI) differ in patients undergoing intermediate/high complexity surgery for advanced ovarian cancer(AOC) when treated by primary (PDS) or Interval (IDS) debulking surgery? Viren Asher
EP786 Telomere length and its implication as prognostic marker in ovarian cancer patients David Atallah
EP787 Characteristics of ovarian tumors in Lebanon: 20 years of experience in a Lebanese tertiary center David Atallah
EP788 Lebanese experience with cytoreductive surgery in ovarian cancer: a single institution series David Atallah
EP789 Sequential use of Risk Malignancy Index and Ca-125 in evaluating adnexal masses Anupama Bahadur
EP790 What is initial in ovarian cancer, changes in metabolism or in histological structure of the organ? Valeria Bandovkina
EP791 Dissociation between systemic and local hormonal profiles in young patients with ovarian cancer Valeria Bandovkina
EP792 Some biological characteristics of malignant transformation of ovaries preserved after hysterectomy Valeria Bandovkina
EP793 Ovarian teratoma- One Case Report . M.Barrientos Hernández MD,Dora Barrientos Hernández MD Dora Barrientos Hernandez
EP794 A meta-analysis of morbidity and mortality in primary cytoreductive surgery compared to neoadjuvant chemotherapy in advanced ovarian malignancy Helena C Bartels
EP795 Searching for the best maintenance therapy in platinum-sensitive recurrent ovarian cancer: bevacizumab or PARP-inhibitors? A network meta-analysis. Michele Bartoletti
EP796 Estrogen receptors alpha and beta in prediction of the front-line platinum plus taxane chemotherapy efficacy in III stage serous high-grade ovarian cancer patients Anna Basharina
EP797 20 years of ultra radical surgery for ovarian cancer patients in Perth Western Australia, what have we learnt? Lachlan Baxter
EP798 Diagnostic accuracy of Gynecology Imaging Reporting and Data system in evaluation of adnexal Lesions Fariba Behnamfar
EP799 Intraoperative molecular analysis during interval cytoreduction of high-grade serous tubo-ovarian carcinoma to confirm necessity for visceral resection. James Patrick Beirne
EP800 Outcome and treatment of ovarian cancer - a retrospective study Tobias Berg
EP801 Malignant ovarian mixed germ cell tumor: case report of a rare combination. Ruben M Betoret Gustems
EP802 Therapeutic role of pelvic and para-aortic lymphadenectomy in apparent early stage epithelial ovarian cancer Nicolò Bizzarri
EP803 The real-world effect of olaparib in BRCA-dependent platinum-sensitive recurrent ovarian cancer patients in Poland Pawel Blecharz
EP804 Prognostic role of second-line platinum-based therapy in recurrent platinum resistant ovarian cancer patients- data from real-world clinical practice in Poland. Lubomir Bodnar
EP805 Primary Malignant lymphoma of cervix misdiagnosed as an ovarian cyst on ultrasonography: A case report Somayeh Bolandi
EP806 First insight of a tailoring Chemotherapy Intensity regimen in a Real life Cohort of Elderly patients with ovarian cancer: The CIRCE study Lucia Bortot
EP807 The risk of malignancy of unilocular ovarian cysts: a systematic review and meta-analysis Laura Buggio
EP808 evaluating the clinical features of adnexial masses during pregnancy results with radiologic findings Halime Cali
EP809 Survival and prognostic factors in patients with recurrent low-grade epithelial ovarian cancer: an analysis of five prospective phase II/III trials of NOGGO metadata base Emel Canaz
EP810 Expression of BRCA1 and Prognosis in Ovarian Cancer: a Systematic Review and Meta-analysis Francisco Jose Candido dos Reis
EP811 A Retrospective Study Regarding the Role of Cytoreductive Surgery (CRS) and Hypertermic Intraperitoneal Chemotherapy (HIPEC) in Patients with Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer Mihai Emil Capilna
EP812 Impact of incorporation of extensive surgical procedures on surgical outcomes in advanced ovarian cancer Laura Cárdenas Puiggrós
EP813 Different prevalence and pattern of lymph nodes metastases between primary and interval cytoreduction in advanced ovarian cancer Laura Cárdenas Puiggrós
EP815 Ultrasound-based score for predicting debulking surgery outcome in IIB-IV stage epithelial ovarian cancer Enrique Chacón
EP816 TRPV1 and PTEN expression is related to poor prognosis in epithelial ovarian cancer Doo Byung Chay
EP817 The Impact of urological complications during surgical treatment for advanced ovarian cancer Radoslav Chekerov
EP818 Primary debulking surgery versus primary neoadjuvant chemotherapy with or without interval debulking surgery for advanced stage ovarian cancer: a single institute study Ying Yi Chen
EP819 Two Cases of Erythema Nodosum in Patients on Olaparib Mandy Man Yee Chu
EP820 MR and ultrasound fusion imaging to characterize ovarian masses Adrien Crestani
EP821 Short-term safety and outcomes of HIPEC in ovarian cancer patients Andreia Cruz
EP822 Simvastatin enhances the anti-tumoral effect of metronomic cyclophosphamide against cancer-initiating cells (CICs) by reducing ALDH1A1 expression both in vitro and in vivo: an effective combination to overcome resistance and limit the spread of the recurrent disease in high-grade serous ovarian cancer (HGSOC). Mauricio A. Cuello
EP823 Patients with stage IV epithelial ovarian cancer: Understanding the determinants of survival Yohann Dabi
EP824 Ambiguous diagnoses of borderline ovarian tumors at frozen section with a definite diagnosis of invasive carcinoma: consequences for counseling and perioperative treatment. Koen De Decker
EP825 The Malignant Transformation of a Dermoid Cyst: A Case Report Maria Rheapaz De Guzman
EP826 Unchanged morbidity despite increased surgical radicality in cytoreductive surgery for an advanced stage epithelial ovarian cancer. Diederick De Jong
EP827 Pathologic findings in risk-reducing salpingo-oophorectomy (RRSO) in women with BRCA1 or BRCA2 mutations: a single center experience Antonio De Leo
EP828 Whole genome sequencing and clinical drug response data of 142 ovarian cancer samples Chris J. de Witte
EP829 The need for and the development of a decision aid for primary treatment of advanced stage ovarian cancer patients Judith Elisabeth den Ouden
EP830 DICER1 and FOXL2 genes mutation in juvenile granulosa cell tumor (A TMRO study) Mojgan Devouassoux-Shisheboran
EP831 Extensive upper abdominal surgery and Hudson hsyterectomy for advanced stage ovarian cancer patients. Our 23 month experience Nasuh Utku Dogan
EP832 Mucinous cystic tumor with mural nodules: anaplastic carcinoma and sarcoma like-nodules - case report Katarzyna Drosik-Rutowicz
EP833 The prognostic impact of Sphingosine-Kinase 1 expression (SphK1) on ovarian cancer Zacharias Drosos
EP835 Value of reducing intraperitoneal cisplatin dose In debulked advanced epithelial ovarian cancer Ahmed Elagwany
EP836 Clinical applicability of simplified PCI in advanced ovarian cancer staging and correlation with CT SPCI Ahmed Elagwany
EP837 Pelvic Schistosomiasis an incidental finding in a suspected gynaecology cancer patient- A Case Report Alaa El-Ghobashy
EP838 Current status of oncofertility care for the AYA cancer patients with ovarian germ cell tumors in Japan - a fact-finding survey by Japan agency for medical research and development (AMED) Hiraku Endo
EP839 Damage control surgery for the management of a complication of ovarian cytoreductive surgery Silvia Espuelas Malón
EP841 Bilateral ovarian solid tumors in young female with autosomal dominant inherited genetic syndrome Osmar Ferreira Rangel Neto
EP842 Role of thyroid system in malignant transformation of ovaries in women with previously removed uterus Elena Frantsiyants
EP843 Hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer: evaluation of side effects in a single institution cohort Michael Friedrich
EP844 Elaidic acid promotes cell proliferation and migration via LSR in epithelial ovarian cancer Masashi Funauchi
EP845 Serous Tubal Intraepithelial Carcinoma in the opportunistic salpingectomy. A case review at Mataró Hospital Bruna Furriols Raulí
EP846 Parenchymal splenic metastasis from ovarian cancer; a report of two cases and literature review Khaled Gaballa
EP847 CA 125 as a prognostic marker for the stage of patients with ovarian carcinoma Anita Ganovska
EP848 Overexpression of DUSP6 enhances chemotherapy-resistance of ovarian epithelial cancer by regulating the ERK signaling pathway Yan Gao
EP849 Evaluating the Benefits of Neoadjuvant Chemotherapy for Advanced Epithelial Ovarian Cancer Yan Gao
EP850 Incidence and survival impact of abdominal wall metastases in advanced low-grade serous epithelial ovarian cancer: a single center experience Annalisa Garbi
EP851 Treatment outcomes of germ cell tumours of ovary: single institutional study Sumedha Gargy
EP852 Ovarian cancer recurrence post ultraradical primary debulking. Role of HIPEC. Eirini Geramani
EP853 The feasibility of robot-assisted laparoscopic staging in early-stage epithelial ovarian cancer. C.G. Gerestein
EP854 How did to improve the overall survival of patients with advanced serous ovarian cancer? Evgeniya V Gerfanova
EP855 Metachronous brain metastases in ovarian cancer Amal Ghidhaoui
EP856 Optimal residual disease at primary debulking surgery versus complete tumor resection at interval debulking surgery in advanced epithelial ovarian cancer: a case-control survival analysis Valentina Ghirardi
EP857 Distinguishing benign vs. cancer states in ovary based on spectrochemical analysis of ascites: a budget omics approach Panagiotis Giamougiannis
EP858 What you should know about tumor reductive surgery in advanced ovarian cancer - Clinical recommendations from a patient perspective Karen Rosnes Gissum
EP859 Endocrine-disrupting chemicals present in human follicular fluid disrupt granulosa cell tumors E2 secretion dependent on estrogen metabolism potential. Justyna Gogola
EP860 Redox status of the blood of patients with ovarian cancer with different prevalence and course of the disease Irina Goroshinskaya
EP861 Precision medicine tumor boards: applicability of personalized treatment concepts in ovarian cancer Christoph Grimm
EP862 Double rare association of malignant ovarian tumors : Endocrine and lymphoma ovarian tumors a bout one case Fatiha Hadjarab
EP863 Ovarian primitive lymphoma :experience of department of medical oncology Algiers ,Algeria Authors : F.HADJARAB1 , CE CHEKMAN 2 , A.TAIBI 1 , K.BOUZID 1 1: Medical Oncology , CENTER PIERRE MARIE CURIE ALGIERS ALGERIA 2: Surgery Fatiha Hadjarab
EP864 BRCA screening and burden of treatment among patients receiving active therapy for ovarian cancer Jennifer Hall
EP865 Forkhead box protein O1 and Paired box gene 3 overexpression is associated with poor prognosis in patients with epithelial ovarian cancer Gwan Hee Han
EP866 Prognostic and predictive implication of hormonal receptors expression and tumor infiltrating lymphocyte in epithelial ovarian cancer. Gwan Hee Han
EP867 Tumor suppression by FAT4 occurs by acting through retinoblastoma pathway in epithelial ovarian cancer Shika Hanif
EP869 Treatment of Ovarian Cancer in Germany from 2004-2016. Results of a nationwide quality assurance program (QS Ovar) Philipp Harter
EP870 Bevacizumab facilitates surgery in previously inoperable patients with low-grade serous ovarian cancer: a case series Helen Hockings
EP871 Impact of surgical restaging on recurrence in patients with borderline ovarian tumors: A meta-analysis. Cyrille Huchon
EP872 Ovarian cancer and HIPEC: Survey for causes, symptoms and treatment multidisciplinary approach - the gynae-oncologists perspective C. Iavazzo
EP873 thinking ouside the box- hyperthecosis in postmenpause Elzahra Ibrahim
EP874 Serologic markers of Chlamydia trachomatis and other sexually transmitted infections and subsequent ovarian cancer risk: Results from the EPIC cohort Annika Idahl
EP875 Novel clinical roles for BRCA1/2 germ-line status: 1) Primary surgery is superior to neoadjuvant chemotherapy in sporadic but not in hereditary ovarian cancers; 2) Favorable anatomic pattern of relapses in BRCA1/2 mutation carriers Evgeny Imyanitov
EP876 Oncologic outcome of cystectomy compared with unilateral salpingo-oophorectomy in the treatment of stage I borderline ovarian tumors Tae-Kyu Jang
EP877 Intestinal (sub)obstruction in ovarian cancer patients: management, complications and survival Jolien Jansen
EP878 Anastomotic bowel leakage after cytoreductive surgery in advanced epithelial ovarian cancer surgery: relation to surgical specialty and complexity score. Ulrika Joneborg
EP879 Peritoneal cancer index (PCI) is a strong predictor of operability in ovarian cancer Björg Jónsdóttir
EP880 Analysis of oncologic and reproductive outcomes after fertility-sparing surgery in young women with malignant ovarian germ cell tumor U Chul Ju
EP881 Neoadjuvant chemotherapy for newly diagnosed ovarian cancer: a single center experience Maria Kaparelou
EP882 Risk of ovarian malignancy algorithm performs better than CA125&HE4 alone in a clinical setting Mikhail Katsyuba
EP883 Repeated use of maintenance therapy olaparib in patients with platinum-sensitive relapse of ovarian cancer Svetlana Khokhlova
EP884 Synchronous primary carcinoma in left tubal carcinosarcoma and right tubal serous carcinoma: a case report Nea Ry Kim
EP885 Oncologic safety of closed suction technique in removal of huge ovarian cyst Nam Kyeong Kim
EP886 Atypical endometriosis associated with ovarian malignancy Naery Kim
EP887 A synergistic anticancer effect of combination treatment with a cell cycle checkpoint kinase 1 inhibitor and PARP inhibitor in BRCA wild type epithelial ovarian cancer Yong Beom Kim
EP888 The impact of levels of biomarkers on overall survival in FIGO stage III-IV ovarian cancer Preben Kjølhede
EP889 Improved cytoreduction of ovarian cancer using CD24-targeted fluorescence image-guided surgery in a preclinical murine model Katrin Kleinmanns
EP890 Primary ovarian small cell carcinoma of pulmonary type with enlarged paraaortic lymph node masses: a case report and review of the literature. Eleftherios G. Klonos
EP891 Receptor activator of nuclear factor kappa-B ligand expression predicts ovarian cancer Outcome Johanna Kögl
EP892 How can collaboration with surgical oncologist change paradigm in the treatment of advanced ovarian cancer: a retrospective cohort study Viacheslav Kopetskyi
EP893 Malignant Bowel Obstruction in Gynaecological Oncology: Are There Alternatives to Surgery or Palliation Following Failed Conservative Management? Porfyrios Korompelis
EP894 Evaluation of the clinical usefulness of HE4 and CA125 assays in monitoring treatment response of patients with advanced ovarian cancer. Beata Kotowicz
EP895 Primary Squamous Cell Carcinoma of the Ovary. Review of the literature. Nektarios Koufopoulos
EP896 Ovarian metastasis from colorectal carcinoma: A case report and review of the literature. Antonios Lagkadas
EP897 Clinical application of the sentinel lymph node technique in early ovarian cancer: phase II clinical trial Victor Lago
EP898 The prognostic role of age, timing of surgery and surgical radicability in patients with advanced stage epithelial ovarian cancer; a single institution experience Alexandros Laios
EP899 Diagnostic value of postoperative Platelet-to-White Blood Cell Ratio (PC/WCC) after splenectomy in advanced ovarian cancer patients. Kostas Lathouras
EP900 The impact of age on the management of patients with ovarian cancer Maria Elena Laudani
EP901 Aldehyde dehydrogenase inhibitors (as potential anti-chemoresistance drugs for ovarian cancers Taek Sang Lee
EP902 Single port access laparoscopic staging surgery in patient with early stage ovarian cancer San-Hui Lee
EP903 Prognostic factors for BRCA mutation in ovarian cancer patients Nara Lee
EP904 Clinical outcomes of post-operative intraperitoneal chemotherapy for patients with early stage high grade serous ovarian cancer treated at British Columbia Cancer Agency Shaina (Joohyun) Lee
EP905 Ovarian cancer treatment in the elderly Michail Liontos
EP906 Pre-operative prediction of residual disease after interval debulking surgery for advanced stage epithelial ovarian cancer using a multivariable model with HE4 Pien Lof
EP907 Hyperthermic intraperithoneal chemotherapy (HIPEC) for ovarian cancer treatment: the feasibility study Marta Lomnytska
EP908 Expression of CD24 in ovarian cancer Janos Lukacs
EP909 Influence of intraoperative administration of ketorolac on the prognosis of ovarian cancer Mathieu Luyckx
EP910 Non-epithelial ovarian cancer in Tunisia: Clinical presentation, treatment and outcome Ikram Marghli
EP911 Adjuvant chemotherapy versus surveillance in stage I non epithelial ovarian cancers: A single center experience Ikram Marghli
EP912 Characterization of the tumour microenvironment in high-grade serous ovarian cancer (HGSOC): prognostic value of the lymphocytic infiltration patterns and immune-related genes. Josep Marí-Alexandre
EP913 A comparative study of three different managements after colorectal anastomosis in ovarian cancer: conservative management and observation, diverting ileostomy and ghost ileostomy Tiermes Marina
EP914 Port site resection after laparoscopy in advance ovarian cancer surgery: Time to abandon? Tiermes Marina Martín
EP915 Granulosa Cell Tumor of Ovary: A retrospective study of 16 Cases. Carmen Martín Blanco
EP916 Lymph node involvement pattern and survival differences in a retrospective analysis of individual results prior to change our strategy about de role of lymphadenectomy in management of ovarian cancer Ester Martínez Lamela
EP917 Retrospective analysis of the prognostic factors for disease recurrence and overall survival in patients with ovarian cancer. A single center study Ester Martínez Lamela
EP918 Transvaginal/Transabdominal Sonography for Histological Diagnosis in Advanced Ovarian Cancer Patients: A Single Institution Prospective Study. Floriana Mascilini
EP919 Obesity and inflammation combined are risk factor for early recurrence in High Grade Serous Ovarian Cancer Munoz Matias
EP920 Ovarian cancer and BRCA mutation typing: a review of cases in Northern Ireland 2018 Jennifer Mcinerney
EP921 Lymphocytic and cytokine microenvironment of ovarian cancer Anna Menshenina
EP922 Dependence between the degree of endogenous intoxication and levels of serological markers in ovarian cancer Anna Menshenina
EP923 Smoothened protein expression and promoter methylation status in serous ovarian carcinomas Pavao Mioc
EP924 Clinical Characteristics Predictive of Optimal Primary Cytoreduction in Epithelial Ovarian Malignancy: A Five-year Retrospective Study in a Tertiary Government Hospital Jehada Misuari-Alihuddin
EP925 Cytoreductive surgery in Stage IIIC and IV epithelial ovarian cancer, a prospective cohort study Vasileios Mitsopoulos
EP926 PAD enzymes as a candidate therapeutic target in ovarian cancer. Bashir Mohamed
EP927 Ex-vivo antitumor efficacy of PEGylated-targeted nanodiamonds for docetaxel delivery in ovarian cancer Bashir Mohamed
EP928 Kallikrein and plasmin in ascitic fluid require exogenous inhibitors in ovarian cancer and tuberculosis of uterine appendages Tatiana Moiseenko
EP929 Survival impact of different surgical strategies in advanced stages ovarian cancer. Analysis in a single center and self-criticism of our outcomes. Jesús Molero Vílchez
EP930 The prognostic value of PARPexpression in high grade epithelial ovarian cancer Szabolcs Molnár
EP931 Variations in BRCA screening and treatment patterns among ovarian cancer patients in Europe and the United States Matthew Monberg
EP932 Impact of FDG-PET/CT in initial staging of primary advanced ovarian cancer Bibiana Morillas
EP933 Thromboembolic events post cytoreductive surgery in patients with ovarian, fallopian tube or primary peritoneal cancer Malak Moubarak
EP934 Predictive factors of postoperative complications after cytoreductive surgery for ovarian cancer Malak Moubarak
EP935 The inflammatory response following HIPEC - a novel therapeutic window Karen Mulligan
EP936 A feasibility study of gemcitabine and bevacizumab in women with platinum-resistant recurrent ovarian cancer. Shoji Nagao
EP937 Frailty assessment in treatment for elderly patients with ovarian cancer Reiko Nakamura
EP938 Plasmajet In ovarian cancer Surgery Purushothaman Natarajan
EP939 Neoadjuvant chemotherapy (NAC) for patients with carcinomatosa peritonitis improves prognosis of those patients Masato Nishimura
EP940 Chemokine expression in patients with ovarian cancer or benign ovarian tumors Marek Nowak
EP941 Synchronous Ovarian and Endometrial Cancers; a 10-year Retrospective Review in a UK Tertiary Centre. Rachel Louise O'Donnell
EP942 Incorporating Tumour Biology into Follow-up Strategies in Ovarian Cancer: Can Tumour CA125 Status Dictate Utility of Serum CA125 in the Detection of Recurrence? Rachel Louise O'Donnell
EP943 Prognostic significance of pretreatment serum carcinoembryonic antigen (CEA) level in epithelial ovarian cancer Yu-Che Ou
EP944 Isolated Lymph node recurrence in epithelial ovarian cancer: a recurrence with better prognosis? Lobna Ouldamer
EP945 Lymphovascular invasion in ovarian cancer Lobna Ouldamer
EP946 Differences in correlation of Progression-Free Survival and Overall Survival by clinical variables in epithelial ovarian cancer E Sun Paik
EP947 Recurrent Ovarian Cancer Treated by Secondary Cytoreductive Surgery and HIPEC Theo Panoskaltsis
EP948 Prognostic Value of Metastatic Lymph Nodes in Advanced Ovarian Cancer Surgery with HIPEC Theo Panoskaltsis
EP949 Cytoreduction plus HIPEC in advanced ovarian cancer: 10-year experience of the Naval and Veterans Hospital of Athens. Katerina Papakonstantinou
EP950 Predictive value of biomarkers during chemotherapy in patients with epithelial malignant ovarian cancer. Giulia Parpinel
EP951 The predictive value of prognostic nutritional index in diagnosing extent of disease and postoperative course of ovarian cancer patients: preliminary findings from a pilot study Vasilios Pergialiotis
EP952 Novel molecular target selection for tumour-specific imaging of metastases from epithelial ovarian cancer Inge Peters
EP953 Poor AT and VO2 max recorded during Cardiopulmonary Exercise Testing (CPET) prior to cytoreductive surgery in advanced (Stage 3/4) ovarian cancer (AOC) is associated with suboptimal cytoreduction but does preclude maximum effort cytoreduction. Andrew Phillips
EP954 Impact of Splenectomy on survival in advanced ovarian cancer (AOC) in a propensity matched cohort. Andrew Phillips
EP955 Interval debulking surgery for advanced ovarian cancer in elderly patients (>70y): does the age matter? Ciro Pinelli
EP956 Cardiophrenic node dissection during interval debulking surgery for stage IV ovarian cancer: a case series Ciro Pinelli
EP957 Inflammation biomarkers and differential diagnosis of pelvic tumors: an observational study Victoria Psomiadou
EP959 Fertility-sparing surgery in patients with early stage clear cell carcinoma of the ovary - is it safe to offer? Maili Qi
EP960 Total omentectomy versus omental sampling in early ovarian cancer surgery Basel Refky
EP961 Are there opportunities to improve the number of women able to start and tolerate treatment for ovarian cancer? European perspectives from the World Ovarian Cancer Coalition's Every Woman Study Frances Reid
EP962 Survival outcome and Surgical morbidity analysis of Interval cytoreductive surgery performed for Advanced Epithelial Ovarian Cancer Prabhakaran Nair Rema
EP963 Assessment Of Abdominal Resectability With FDG-PET/CT In Locally Advanced Ovarian Cancer Laia Ribot
EP964 Targeting AKT and DNA-PK as a therapeutic strategy in platinum resistant High-grade Serous Ovarian Cancer. Natasha Rinne
EP965 The impact of clinico-pathological features and surgery on relapse in women with borderline ovarian tumours: our experience Ivana Rizzuto
EP966 Borderline Ovarian Tumours: A single institute retrospective study Ana Carolina Rocha
EP967 Natural history of patients with BRCA-mutated high grade epithelial ovarian cancer (HGEOC) before the era of PARP inhibitors maintenance in 1st line treatment Clémence Romeo
EP968 Practice trend of PLD in Ovarian cancers : Experience from tertiary cancer centre in India Rakesh Roy
EP969 Prognostic value of recurrence patterns in ovarian cancer Joline F Roze
EP970 PIK3R1 mRNA expression is associated with copy number alteration in ovarian cancer. Iwona K. Rzepecka
EP971 Survival impact of wide resection of the pelvic peritoneum in patients with epithelial ovarian cancer Akihito Sagara
EP972 Precision medicine program for epithelial ovarian carcinoma (EOC): first year experience at Clínica Universidad de Navarra (CUN) Luisa Sánchez Lorenzo
EP973 “Tumour First”: An Institutional Experience of Reflex Tumour BRCA Testing in Ovarian Epithelial Carcinomas Giacomo Santandrea
EP974 Review of three cases of high grade serous ovarian cancer associated with cerebellar atrophy and acute inflammatory demyelinating polyneuropathy. Apostolos Sarivalasis
EP975 Risk factors for ovarian cancer: an umbrella review Anita Semertzidou
EP976 The impact of extent of cytoreductive surgery(CRS) on epithelial ovarian cancer(EOC), primary peritoneal carcinomatosis(PPC), and Fallopian tube cancer(FTC) at the American University of Beirut(AUBMC) Muhieddine Seoud
EP977 Impact of timing of cytoreductive surgery (CRS) on epithelial ovarian cancer (EOC), primary peritoneal carcinomatosis (PPC), and fallopian tube cancer (FTC) at American University of Beirut Medical Center (AUBMC) Muhieddine Seoud
EP978 A radiologic-laparoscopic model to predict suboptimal (or complete and optimal) debulking surgery in advanced ovarian cancer: A pilot study Anna Serra
EP979 Clinicopathological and Survival analysis of Ovarian Malignant Germ Cell Tumors; Twenty Five Years Experience of Single Institution Sevtap Seyfettinoglu
EP980 Gonadal vein graft after retroaortic left renal vein injury during paraaortic lymphadenectomy: a case report Sevtap Seyfettinoglu
EP981 Cytoreductive Surgery for Tubo-ovarian Carcinoma - A study of surgical outcomes with primary surgery. Yulia Shahabuddin
EP982 Management of Indeterminate pelvic masses and borderline ovarian tumours: a survey of current practice of gynaecological Oncology Centres in the United Kingdom. Aarti Sharma
EP983 PTEN down regulation induce apoptosis in epithelial ovarian cancer cells. Jin Woo Shin
EP984 Granulosa-cell tumors during ovarian stimulation Laya Shirinzadeh
EP985 Morbidity outcomes of cytoreductive surgery in advanced low grade serous and sex chord stromal tumor TS Shylasree
EP986 Hypoalbuminaemia in Advanced Ovarian Cancer (AOC): Primary or Interval Surgery? Kavita Singh
EP987 Prevalence and spectrum of BRCA mutations in patients with platinum-sensitive ovarian cancer from Romania - results of an observational study Dana Lucia Stanculeanu
EP988 Hematologic markers of survival outcome in epithelial ovarian, fallopian tube and primary peritoneal cancer patients treated with platinum-based chemotherapy Prapaporn Suprasert
EP989 Dependence of blood flow parameters in recurrent ovarian tumors on haptoglobin and ceruloplasmin dynamics in blood Ekaterina Surikova
EP990 Activation of EGFL7 within high grade ovarian serous carcinoma is associated with lower tumor infiltrating CD4+ and CD8+ lymphocytes Jacek Sznurkowski
EP991 Exceptional response with combined anti-hormone and MEK inhibitor therapy in a patient with hormone receptor-positive ovarian cancer and isolated KRAS alteration. Implications for a precision medicine strategy. Kenta Takahashi
EP992 Iron-dependent cell death "ferroptosis" is a new therapeutic strategy for ovarian cancer Motoki Takenaka
EP993 Macrocytosis associated with olaparib Motoki Takenaka
EP994 Epigenetic Silencing of FBXW7 through Promotor Hypermethylation in Ovarian Cancer Yahya Tamimi
EP995 Ultrasound patterns compared to histopathological findings in ovarian granulosa cell tumor Saverio Tateo
EP996 Thermal Liquid Biopsy (TLB) as a new diagnostic tool for patients with Ovarian Cancer: A pilot study Carmen Tauste
EP997 Treatment tailoring in epithelial advanced ovarian cancer: survival results in Navarre Carmen Manuela Tauste Rubio
EP998 Comparison of laparoscopy and laparotomy in the surgical management of early-stage ovarian cancer Natalia Teixeira
EP999 Bevacizumab-related gastrointestinal perforation in patients with three or more prior chemotherapy regimens: a real-world experience Yukiharu Todo
EP1000 Supraclavicular lymph node metastatic spread in a patient with clear cell ovarian carcinoma: an unusual finding Helen Trihia
EP1001 Bilateral neuroendocrine carcinoma of the ovary of the mucinous goblet cell carcinoid type. A very rare tumor entity Helen Trihia
EP1002 Secondary Cytoreduction Surgery for Recurrent ovarian Cancer - Twelve radiological criteria for case selection: preliminary data Efthalia Tsahalina
EP1003 Meigs' syndrome with elevated serum CA125: Case report and review of the literature Christos Tsaousidis
EP1004 Prognostic impact of BRCA2 mRNA expression in ovarian cancer: validation using the TCGA cohort Irina Tsibulak
EP1005 Spectrum and frequency of hereditary BRCA 1/2 mutations in ovarian cancer patients in Ukraine Nataliya Tsip
EP1006 Subxiphoid approach for the resection of enlarged supradiaphragmatic cardiophrenic lymph nodes during primary cytoreduction for advanced ovarian cancer: A case report. Dimitrios Tsolakidis
EP1007 Clavien-Dindo classification of postoperative complications in advanced epithelial ovarian cancer treated by primary or interval debunking surgery. Dimitrios Tsolakidis
EP1008 Modified posterior exenteration in advanced ovarian cancer: A single center experience Dimitrios Tsolakidis
EP1009 Loss of skeletal muscle mass during neo-adjuvant chemotherapy and the relation to survival in patients with ovarian cancer; a prospective analysis of the OVHIPEC-1 cohort Jorne Ubachs
EP1010 The Clinical Outcomes of Neoadjuvant Therapy with Cisplatin plus Mitomycin in BRCA1-Mutated Ovarian Cancer Elena Ulrikh
EP1011 CA 125 in Borderline Ovarian Tumors Esra Uyanık
EP1012 Giant Ovarian Mucinous Cystadenoma: a case report Esra Uyanık
EP1013 Overview of non-epithelial ovarian tumours: Incidence and survival in the Netherlands Olga L van der Hel
EP1014 Signal transduction pathway activity in normal Fallopian tube epithelium and high-grade serous carcinoma Phyllis van der Ploeg
EP1015 Is Endometriosis Always Benign? Dimitra Vasileiadou
EP1016 Evaluation of the antitumor effect of dioxade on the change in the content of free DNA in the blood Irina Vasilyeva
EP1017 Prognostic and Therapeutic Factors for Low-grade Serous Ovarian Carcinoma: A Multicentric, Retrospective Study of the Turkish Society of Gynaecologic Oncology Doğan Vatansever
EP1018 Abnormal antioxidant status of lymphocytes in tumor and blood in ovarian cancer as the cause of their functional failure Ekaterina Verenikina
EP1019 Antioxidant status of tumor and blood neutrophils in ovarian cancer patients as an indicator of immune homeostasis Ekaterina Verenikina
EP1020 Luminescent characteristics of peripheral blood lymphocytes reflect efficiency of treatment in patients with ovarian cancer Ekaterina Verenikina
EP1021 Laparoscopic primary cytoreduction with multi visceral resection in advanced ovarian cancer: the first experience of 5 procedures Alla Vinnytska
EP1022 Primary vs Interval Debulking Surgery for advanced Epithelial Ovarian Cancer: Survival Outcomes from a Tertiary Greek Centre. Dimitrios-Efthymios Vlachos
EP1023 The effect of surgery on patients with stage III ovarian cancer and enlarged supradiaphragmatic lymph nodes Omer Weitzner
EP1024 Assessment of the clinicopathological relevance of interleukin 17 in ovarian cancer patients Iwona Wertel
EP1025 Serum calretinin as liquid biopsy marker for identifying ovarian cancer patients with poor prognosis Pauline Wimberger
EP1026 CD4+IL-21+ and IL-22+ and CD4+FOXP3 in a algorithm ROMA relationship in patients affected by ovarian tumours. Izabela Winkler
EP1027 Ovarian cancer with and without other primary cancers - are these different entities? Lo Wong
EP1028 Metastatic patterns do not provide additional prognostic information in patients with FIGO stage IV high-grade serous ovarian cancer Xiaohua Wu
EP1029 A Preliminary study of genetic susceptibility and treatment related gene profiling in Chinese ovarian cancer patients Xiaohua Wu
EP1030 Apatinib monotherapy in patients with advanced ovarian cancer after platinum resistance : a prospective, exploratory study Xiaoping Xia
EP1031 Ovarian high-grade sarcoma: case report and literature review Shahla Yazdani
EP1032 Late vaginal recurrence of ovarian serocyst adenocarcinoma Shahla Yazdani
EP1033 18F-FDG PET/CT-based metabolic metrics in recurrent tumors of ovarian clear cell carcinoma and their prognostic implications Shuang Ye
EP1034 Comparing The Efficiency of Interval Debulking Surgery after Neoadjuvant Chemotherapy with Primary Debulking Surgery in patients with Stage 3 and 4 Ovarian Carcinoma: Multicenter Real World Data Mukaddes Yılmaz
EP1035 Comprehensive miRNA sequencing of squamous cell carcinoma arising from ovarian mature teratoma Kosuke Yoshida
EP1036 Association of TNF-308 G>A polymorphism located in tumor necrosis factor a with the risk of developing cervical cancer and results of pap smear. Zohreh Yousefi
EP1037 Predictive Accuracy of the Risk of Malignancy Index and Clinicopathological Results of Patients with Probably Malignant Pure Adnexal Mass (Without Acidity and Implantation) Harika Yumru Celiksoy
EP1038 Ovarian Malignancy Risk Stratification Using a Third-Generation Multivariate Index Assay Zhen Zhang
EP1039 Resibufogenin inhibits ovarian clear cell carcinoma (OCCC) growth in vivo, and migration of OCCC cells in vitro, by down-regulating the PI3K/AKT and actin cytoskeleton signaling pathways Guannan Zhou
EP1040 Engineered bovine-milk-exosome-mediated delivery of resibufogenin and its enhanced suppression effect in platinum-resistant ovarian cancer cells Guannan Zhou
EP1041 Is there a place for platinum reinduction in BRCA positive platinum-resistant ovarian cancer? Michal Zikan
EP1042 Evaluation of PCTAIRE2 kinase expression in ovarian cancer and ovaries and fallopian tubes with BRCA1 mutation. Patrycja Ziober-Malinowska
EP1043 Comparison between "Fagotti" diagnostic laparoscopy and "Suidan" criteria for the avoidance of suboptimal laparotomies in advanced ovarian cancer. Dimitrios Zouzoulas
EP1044 Preoperative Computed Tomography Predict unresectability in Primary Cytoreductive Surgery for Advanced Ovarian Cancer Jing Zuo
EP1045 Differences of tumour behaviour among various types of epithelial ovarian cancer 昱任
EP1046 Living life in the face of loss: parenteral nutrition in ovarian cancer patients in bowel obstruction Andrew Clamp
EP1047 The Prognostic Nutritional Index is Useful for Predicting the Prognosis of Patients with Terminal-stage Gynaecologic Cancer Takashi Hirayama
EP1048 Imaging-guided percutaneous radiofrequency ablation of retroperitoneal metastatic disease in patients with MMMT; clinical experience with two patients Minjin Jeong
EP1049 Perceived Stress, Self-esteem and Self-rated Health in Women with Breast Cancer Receiving Chemotherapy Treatment. Anna Koumarianou
EP1050 Effects of an 8-Week Stress Management Program in Women with Breast Cancer: A Randomized Controlled Trial Anna Koumarianou
EP1051 Is treating malignant obstructive uropathy in advanced cervical cancer as futile as we think? Devyani Mahajan
EP1052 First experience in palliative care for patients with cancer type pain at the Mohammed VI center for the treatment of cancer Oumaima Omran
EP1053 Palliative urinary diversion in patients with malignant ureteric obstruction due to gynecologic cancer Tamar Perri
EP1054 Symptom burden and operational metrics in gynecological cancer patients cared by a palliative care team, in Greece Aliki Tserkezoglou
EP1055 Interprofessional simulation training to improve gynecologic oncology palliative care knowledge, interdisciplinary education perceptions and teamwork attitudes in health professional students Fatma Uslu Sahan
EP1056 Quality of life assessment before and after concentrated ascites reinfusion therapy in patients with advanced or recurrent gynecologic cancer: a prospective cohort study Kasumi Yamamoto
EP1057 Utilization and timing of Advance Statements on Life-Sustaining Treatment decisions in patients with recurrent gynecologic cancer Ga Won Yim
EP1058 Efficacy of the endocervical curettage vs endocervical brushing for the detection of high grade endocervical dysplasia. Cristina Almansa González
EP1059 Effects of oral probiotics administration in the human papillomavirus infection and its intraepithelial cervical lesions Melanie Cristine Alonzo Martínez
EP1060 Optimal triage of HPV-positive test results Jeff Andrews
EP1061 Risk-reducing surgery in patients with high risk of ovarian and endometrial carcinoma: Single institution experience over 10 years using a standardized surgical-pathological protocol. Rupali Arora
EP1062 Hyperplastic processes in hormone-dependent organs in women after IVF Farida Ayupova
EP1063 Analysis of expression of microRNA a new method for the diagnosis and prognosis of preinvasive cervical carcinoma. Igor Berlev
EP1064 Clinical and pathologic findings of risk-reducing surgery in high-risk breast/ovarian cancer women Margarida Bernardino
EP1065 Comparison of two self-sampler devices for cervical screening in a South African population. Anne Breidenthal
EP1066 Opportunistic Salpingectomy as a Risk Reducing Strategy for High-Grade Serous Carcinoma: A Northern Ireland Opinion Adam Geoffrey Brown
EP1067 Malignant transformation of extra-ovarian endometriosis: A PRISMA-compliant systematic review Cheng Cheng
EP1068 CO2 Laser ablation for cervical intraepitelial neoplasia:retrospective study at "Ramón y Cajal" University Hospital. Cristina del Valle Rubido
EP1069 Vulvar and vaginal intraepithelial neoplasia:CO2laser ablative therapy at Ramón y Cajal University Hospital Cristina del Valle Rubido
EP1070 Risk-Reducing Salpingo-Oophorectomy In Brca Mutation Carriers. A prospective multicentric study. Vittoria Del Vecchio
EP1071 Genotype distribution of HPV in patients with histologically proven findings for cervical intraepithelial neoplasia or invasive cervical cancer in Macedonia Goran Dimitrov
EP1072 Diagnostic performance of p16/Ki67 immunostaining in postmenopausal women with ASC-US and LSIL cytology Andraž Dovnik
EP1073 The prevalence of squamous intraepithelial lesions according to ethnic affiliation in Macedonia Elena Dzikova
EP1074 Prevalence of high risk human papillomavirus infection among Iranian women using COBAS HPV DNA testing Farah Farzaneh
EP1076 Dependence between arterial hypertension and endometrial hyperplasia in pre- and postmenopausal women Anita Ganovska
EP1077 Argon-assisted loop electrosurgical excision procedure, “Argon-Leep”: a feasible and cheap technique to reduce the smoke and thermal damage during cervical conization. Christina Goudeli
EP1078 HPV self-sampling as an alternative to pap smear collection in outpatient office - women´s considerations Joanna Kacperczyk-Bartnik
EP1079 Clearance of HPV in Women received conization related with Mycoplasma and Ureaplasma. Chan Joo Kim
EP1080 Oooops...very low incidence of HPV infection in patients with CIN2+ in Serbia!Why? Vesna Krsic
EP1081 Human Papillomavirus Genotype and E6 Oncoprotein Molecular Test among Cervical Cancer Patients at Center Mohammed VI for Cancer Treatment Zaineb Lakehayli
EP1082 Study on the knowledge of the human papilloma virus: survey of 538 adult women Amina Lubrano
EP1083 DNA methylation of L1 region of HPV 16, 18 as an approach for hrHPV-positive pregnant women triage Iryna Muryzina
EP1084 The change of opinions on HPV vaccination in Japan: A 5-year follow-up survey of obstetricians and gynecologists regarding their opinions about the HPV vaccine. Yoshikazu Nagase
EP1085 Surgical margins of large loop excision of the transformation zone: histological comparison with patient characteristics and colposcopists' experience Khalil Razvi
EP1086 Diagnostic Accuracy of Conventional Cervical Cytology (Papanicolau Smear), Liquid Based Cytology and Visual Inspection with Acetic Acid in Detecting Premalignant and Malignant Cervical Lesions among Filipino Women in a Tertiary Hospital Roxanne Rivera
EP1087 HPV infection and histological abnormality of uterine cervix in relation to sexual behavior in Japanese young women Masayuki Sekine
EP1088 Pelvic leiomyomatosis ( about a case and literature review ) Meryem Serraj
EP1089 The screening and deasise histories of women with invasive cervical cancer Vera Terenteva
EP1090 Use of HPV-vaccine in prevention of recurrent HSIL after LEEP in women of reproductive age Alla Vinnytska
EP1091 Possible influencing the quality of life of patients with endometrial cancer and cervical cancer after radical treatment Meri Adamyan
EP1092 Predictors of gas passage time interval at postoperative period in gynecologic oncologic surgery; is drainage necessary? Murat Api
EP1093 Comparison of the Effects of Vaginal Honey Jelly with Vaginal Lubricant Gel on Atrophic vaginitis symptoms and Quality of life in Post-Menopausal Women with Endometrial cancer Haleh Ayatollahi
EP1094 Quality of life assessment in gynae-onco survivors Anupama Bahadur
EP1095 Timing of urinary catheter removal after radical hysterectomy. A single institution study Jimmy Billod
EP1096 Implementing Enhanced Recovery After Surgery (ERAS) Pathways In Major Gynecologic Oncology Operations In Greece ( The pre-eliminary results of our department). Maria Bourazani
EP1097 Quality of life and sexuality in breast and gynecological cancers , a pilot study. Raffaella Bracci
EP1098 Sexual health in women with vaginal atrophy. Results of a non-hormonal vaginal gel in women with severe dyspareunia Juan Luis Delgado Marín
EP1099 Intravesical sodium hyaluronate for treatment of cystitis & bladder pain in women with pelvic malignancies Alison DeMaio
EP1100 Body mass index and sexual function in women with gynaecological cancer Hannah Donkers
EP1101 Efffect of a non-hormonal mucoadhesive polycarbophilic vaginal gel on prevalent vaginal symptoms in women who develop vaginal atrophy Jose Estevez Tesouro
EP1103 Can fibrin sealant agents applied after lymph node dissection in patients with gynecological malignancies prevent lymphocele formation? A systematic review and meta-analysis of randomized controlled trials. Christos Iavazzo
EP1104 Lower Extremity Lymphedema in Gynecologic Cancer Patients : Propensity Score Matching Analysis of External Beam Radiation versus Brachytherapy Hyun-Cheol Kang
EP1105 The Role of Stress, Age and Adjuvant Therapy in Cognition of Patients with Breast Cancer. A Systematic Review. Anna Koumarianou
EP1106 Evaluation of a Late Gastrointestinal Effects of Radiotherapy Clinical Nurse Specialist attending a Gynaecological Oncology Follow-up Clinic Nabihah Malik
EP1107 Implementation and feasibility of a digitized self-management intervention targeting cancer patients Mette Linnet Olesen
EP1108 Creatsas modified vaginoplasty as stenosis vaginal treatment after pelvic radiotherapy Pablo Padilla-Iserte
EP1109 Hormone replacement therapy for BRCA-mutation carriers: attitudes of Israeli health-care providers before and after a brief educational intervention Tamar Perri
EP1110 Sexual dysfunction impairment in gynaecological cancer survivors: systematic review Stamatios Petousis
EP1111 Effectiveness of drainage following laparoscopic pelvic lymph node dissection Kensuke Sakai
EP1112 The impact of chemo radio therapy: A qualitative study Nicoline J Schuur
EP1113 How a gynecologic oncology unit became "the happiest place on earth” Richard Schwameis
EP1114 Assessment of quality of life after diagnosis and treatment of gynecologic-oncology patients - review of the literature Mile Tanturovski
EP1115 Parametrium tumor (lymphocyst) after adnextomy on the same side: case report Athanasios Z. Tolkos
EP1116 Integrated pathway analysis identifies a 3-gene signature predicting platinum response and outcome of high grade serous ovarian carcinoma patients Eliana Bignotti
EP1117 Unravelling BRCA1-dependent molecular mechanisms in ovarian cancer by multi-level proteomics Melissa Bradbury
EP1118 Patient-derived ovarian cancer organoids resemble clinical response to chemotherapeutics and provide insights into response mechanisms Chris J. de Witte
EP1119 Fischer rate 344 with syngeneic epithelial ovarian cancer (EOC) cells NuTu 19: key points for building a reliable ovarian carcinomatosis animal model Pierre-François Dupré
EP1120 Application of the Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) to patients conservatively treated: outcomes from an Institutional series Francesca Falcone
EP1121 The clinical potential of FOXL2 c.402C>G mutation detection in circulating tumour DNA of patients with granulosa cell tumours Jolijn W. Groeneweg
EP1122 Detection of non-haematopoetic circulating cancer-related cells in patients with rare gynaecological cancers Marcia Hall
EP1123 Apoptotic effect of herbal product, Gyejibokryunghwan on uterine sarcoma cells Min Hyung Jung
EP1124 CKD-602, a topoisomerase I inhibitor, induces apoptosis and cell-cycle arrest and inhibits invasion in murine cervical cancer Yuyeon Jung
EP1125 Chemotherapy reduces par glycohydrolase (PARG) expression in high-grade serous ovarian cancer patients Vanessa Lopez-Ozuna
EP1126 Single-cell RNA-sequencing of 7 HGSOC cases reveals multiple prognostic cell subtype. Siel Olbrecht
EP1127 Compared the expression of endoplasmic reticulum stress and their adaptive molecule mRNA in endometriosis and gynecologic cancer Dong Choon Park
EP1128 Differential DNA Methylation in High Grade Serous Ovarian Cancer (HGSOC) is associated with Tumor Behaviour Henry D. Reyes
EP1130 Clinical significance of autophagy related molecules in liquid biopsy of cervical cancer Alpana Sharma
EP1132 A comperative molecular analysis of DNA damage response and apoptosis of malignant granulosa cells after exposure to gemcitabine and cisplatin Dogan Vatansever
EP1133 Duration of chemotherapy for normalization of BHCG and treatment outcomes of gestational trophoblastic neoplasia at a tertiary cancer centre in Saudi Arabia Faisal Azam
EP1134 Gestational Trophoblastic Disease (GTD): A 23-years single institution experience Susana Baptista de Almeida
EP1135 A Series of Missing Primaries: Pulmonary Metastasis in Gestational Trophoblastic Neoplasia in the Absence of Uterine Tumors Gillian Patrick Gonzalez
EP1136 Outcome of gestational trophoblastic disease in Lower Egypt. Reda Hemida
EP1137 Primary Gestational Choriocarcinoma of the uterine cervix and fallopian tube: The diagnosis of ectopic pregnancy is not always a benign condition Erbil Karaman
EP1138 Ovarian vein thrombosis in a gestational trophoblastic neoplasia patient Im Hyeon Kim
EP1139 Successful treatment of choriocarcinoma with brainmetastasis with cisplatin etoposid: A case report Franziska Metke
EP1140 Evaluation of the Relation between Treatment Results and Predictive Factors in Metastatic and High Risk Gestational Trophoblastic Neoplasia Leila Mousavi seresht
EP1141 Reproductive Outcomes after treatment of patients with Gestational trophoblastic Neoplasia Sunamchok Srijaipracharoen
EP1142 Gestational trophoblastic neoplasia: clinical presentation, treatment and outcomes Siriwan Tangjitgamol
EP1143 Psychological portrait of women after hydatidiform mole evacuation Nataliya Tsip
EP1144 Stage IV choriocarcinoma. Case report and review of literature. Amanda Veiga-Fernández
EP1145 Choriocarcinoma after term delivery: a difficult diagnosis. María Vizcaíno Gómez
EP1146 Clinical response to a second uterine curettage in patients with low-risk gestational trophoblastic disease: a pilot study Fariba Yarandi
EP1147 Limb Preserving Surgery for Necrotic Vulvar Cancer Groin Recurrence Infiltrating The Femoral Artery and Pubic Bone Ahmed Abdelbadee
EP1148 Treatment outcome of patients with carcinoma of vulva - NCI - Cairo experience Ahmed Abdelhamid
EP1149 A rare vaginal lesion - the potential for malignancy Widad Abdelrahman Ramadan
EP1150 Pelvic exenteration for locally advanced vulvar cancer in South-West Wales Ganiy Opeyemi Abdulrahman Jnr
EP1151 A Case Report on Primary Cutaneous Mucoepidermoid Carcinoma of the Vulva and Its Distinct Clinico-Pathologic Identity Joan Kristel Abrenica
EP1152 Prevalence of occult cancer in biopsy proven VIN3 and dVIN in lesions suspicious and not suspicious of malignancy. Viren Asher
EP1153 Skinning Vulvectomy and Conization together in the treatment of Vulvar Intraepithelial Neoplasia (VIN) 3 of the vulva and High Squamous Intraepithelial Neoplasia (HSIL) of the uterine cervix: oral presentation Mete Can Ateş
EP1154 Vulvar midline tumors: is it really necessary bilateral inguinofemoral groin evaluation, in an era of de-escalation surgery? Margarida Bernardino
EP1155 Endoscopic near infrared and indocyanine green to verify the viability of the subcutaneous flap for vulvar cancer Vito Andrea Capozzi
EP1157 A preliminary analysis of adverse prognostic factors in vulval cancer patients treated with radical electro-resection surgery and groin lymphadenectomy Malgorzata Cieslak-Stec
EP1158 Case report: Leiomyosarcoma of the Vulva (STUMP) an incidental finding at Marsupialization of Bartholin´s cyst Trecia Davidson
EP1159 Staging system comparison in vulvar squamous-cell cancer Federico Ferrari
EP1160 Prognostic factor in primary vulvar squamous-cell cancer in the context of FIGO 1988 and 2009 and Brigham and women's vulvar tumor classification system Federico Ferrari
EP1161 Exome analysis of vulvar and vaginal tumors reveals an antigen processing and presentation deficiency Jean-David Fumet
EP1162 Adenoid Cystic Carcinoma of Bartholin´s gland as a challenging clinical and surgical problem. Reporting two new cases and their outcome. Christina Goudeli
EP1163 2 cases of vaginal melanoma treated by robot assisted total vaginectomy. Sungook Hwang
EP1164 Modified oblique versus classical 'lazy S' incision for inguino-femoral lymph node dissection; complications, node count and hospital stay Sadie Jones
EP1165 Induction of chemokine receptor and suppression of inhibitory receptor of CD8 T cell effectively controlled HPV-associated tumor Yuyeon Jung
EP1166 A huge vulva tumor treatment Kyongjin Kim
EP1167 Vaginal Leiomyoma - a case report Ye Zi Kim
EP1168 The influence of obesity on tumor recurrence in vulvar cancer patients Rüdiger Klapdor
EP1169 Laparoscopic pelvic lymphadenectomy in vulva cancer vs postoperative radiation in pelvic area Eleftherios G. Klonos
EP1170 Development of a risk model for survival and recurrence in patients with vulvar squamous cell carcinoma Kim E. Kortekaas
EP1172 Skinning wide local excision with delayed healing for the surgical treatment of vulval intraepithelial neoplasia Alexandros Laios
EP1173 Vulvar Cancer in association with Muir-Torre Syndrome Sofia Lekka
EP1174 Female genital tract melanoma: a 12-year case series with expert pathological review Jonathan Lewin
EP1175 Small cell neuroendocrine tumour of the vagina Niña Kriste Mendoza
EP1176 Treatment of early stage vulvar carcinoma in a pregnant woman: Case Report Franziska Metke
EP1177 New surgical approaches in management of pre-invasive diseases of vulva. Preliminary experience with Plasmajet surgery in management of vulvar intraepithelial neoplasma and Morbus Paget. Martin Michal
EP1179 Keystone flap application in vulvo-perineal reconstructive surgery: a case series of patients with vulvar cancer. Michele Peiretti
EP1180 Incidence and prognostic factors for inguinofemoral lymph node metastasis in patients with a first local recurrence of vulvar squamous cell carcinoma Noortje Pleunis
EP1181 Clonal relationship between lichen sclerosus, differentiated vulvar intra-epithelial neoplasia and non human papillomavirus (HPV) related vulvar squamous cell carcinoma Annefloor W Pouwer
EP1182 Signal transduction pathways in vulvar squamous cell carcinoma; a pilot study Annefloor W Pouwer
EP1183 Sebaceous carcinoma of the vulva: an unexpected diagnosis and review of the literature Ana Rocha
EP1184 Tissue engineered autologous oral mucosa as an innovative procedure for reconstruction surgery in patients with vaginal or vulvar malignancies Roxana Schwab
EP1185 Uncommon direct lymph drainage pathway to deep pelvic nodes in patient with cancer localized in lower third of the vagina Ivana Semeradova
EP1186 Basal cell carcinoma of the vulva: a case report Aubrey Seneris
EP1187 Malignant melanoma of the vulva: a rare presentation Sarah Sghaier
EP1188 Topic treatment of vulvar lichen sclerosus: symptoms control and risk of progression to malignancy. Federica Paola Sina
EP1189 Intensity of oxidative processes in blood of patients with vulvar cancer is associated with remission duration Ekaterina Surikova
EP1190 MAGE-A4 expression depends on p16 status of squamous vulvar cancer. Jacek Jan Sznurkowski
EP1191 Recurrent Vaginal Mucosal Melanoma Treated with Salvage Hypofractionated External beam Radiotherapy and Interstitial Brachytherapy Houman Vaghefi
EP1192 Surgical treatment of the vulva in the absence of a conclusive diagnosis of squamous cell carcinoma, data from a 10 year cohort. Helena C. van Doorn
EP1193 Value of radiotherapy in the management of Paget's disease of the vulva: a retrospective study of 31 patients. Ignace Vergote
EP1194 Primary vaginal leiomyosarcoma: a case report with complete morphological, immunohistochemical and ultrastructural study Enrico Vizza
EP1195 Circulating microRNAs in differential diagnosis of vulvar intraepithelial lesions and vulvar squamous cell carcinoma Kamil Zalewski
EP1196 Radioguided Detection of Sentinel Lymph Node in Vulvar Cancer. Achievements and Limitations Josko Zekan
EP1197 Types and Viral Load of Human Papillomavirus in Vaginal Intraepithelial Neoplasia: A Cross-section Study Fangyue Zhou
EP1198 Interobserver Variability of Eastern Cooperative Oncology Group (ECOG) Performance Status in Gynecologic Oncology Patients Murat Api
EP1199 Validation of Turkish Version of Eastern Cooperative Oncology Group Performance Status (ECOG-PS) for Gynecologic Oncology Patients Murat Api
EP1200 Impact of socio-demographic characteristics on the quality of care in endometrial cancer: an analysis of a national database in the United States Louise Benoit
EP1201 Laparoscopy versus laparotomy for surgical treatment of obese women with endometrial cancer: a cost-benefit comparative analysis Vito Andrea Capozzi
EP1202 The SORT and ACS-NSQIP scores in assessing the surgical outcome of Gynaecological Oncology patients; Performance comparison Alaa El-Ghobashy
EP1203 Cytoreductive Surgery for Tubo-Ovarian Carcinoma - A Study of MDT Decision-making for Primary vs NACT-Interval Surgery Daly, R., Shahabuddin, Y., Thompson, C., Gleeson, N. Noreen Gleeson
EP1204 Knowledge, Attitudes, and Practices of Resident Trainees Regarding Screening for Sexually Transmitted Diseases in Cervical Cancer Patients Gillian Patrick Gonzalez
EP1205 Enhanced recovery after surgery program in older patients undergoing gynaecologic oncological surgery is feasible and safe Camille Jauffret
EP1206 Timely access to genetic counseling for women with epithelial ovarian cancer in Nova Scotia Katharina Kieser
EP1207 Adolescents education about sexuall responsible behavior and preventing HPV infections-health education in Croatia Dubravko Lepusic
EP1208 Enhanced recovery after surgery (ERAS) implementation and outcomes in a UK tertiary gynaecological oncology centre Eva Myriokefalitaki
EP1209 Patient evaluation of group counselling after fast track surgery for gynaecologic cancer Dorte Reventlow
EP1210 Follow-up in gynecologic malignancies, correspondence with ESGO Guidelines- Preliminary Result of ENYGO Survey Ilker Selcuk
EP1211 Observance of hormonal therapy in breast cancer CENTRE MOHAMMED VI FOR CANCER TREATMENT Hind Zaine
EP1212 On the value of a prognostic tumour score in locally advanced cervical cancer Jakob Lindegaard
EP1213 Comparison of survival between abdominal versus laparoscopic radical hysterectomy in cervical cancer: 10 year experience in a single UK cancer centre Nana Gomes
EP1214 Incidence of cervical cancer and other malignancies after treatment of cervical intraepithelial neoplasia: a systematic review and meta-analysis Antonios Athanasiou
EP1215 Postoperative radiotherapy does not benefit stage IB-IIA cervical squamous cell carcinoma with intermediate risk according to Sedlis criteria Xiaohua Wu
EP1216 What are the real-world outcomes of locally advanced cervical cancer patients who receive neo-adjuvant chemotherapy? Kelly Baillie
EP1218 Outcome in 186 patients with cervical cancer stage IB1 treated with radical hysterectomy without adjuvant radiochemotherapy, unless presenting with metastatic lymph nodes. Jolien Haesen
EP1219 Added value of para-aortic surgical staging compared to F18 FDG PET/CT on the external beam radiation field of patients with locally advanced cervical cancer: an ONCO-GF study Marjolein De Cuypere
EP1220 Comparison of laparoscopic versus open radical hysterectomy in early cervical cancer after completing learning curve and reducing intraperitoneal tumor exposure Jeong-Yeol Park
EP1221 Magnetic resonance imaging-assessed tumor free distance to serosa predicts deep myometrial invasion and poor prognosis in endometrial cancer Julie Andrea Dybvik
EP1222 Is conservative surgery appropriate in ovarian granulosa cell tumors with tumor rupture? Sebastien Gouy
EP1223 Fertility-Sparing Surgery in Patients with Borderline Ovarian Tumors and Reproductive Outcomes Plett Helmut
EP1225 How the conformity of surgical practice with the national guidelines improved the quality of management of ovarian Granulosa cell tumors (GCT)? A TMRG and GINECO group study. Céline Lenck
EP1226 Molecular and phenotypic characterisation of intra-tumoural heterogeneity in High Grade Serous Ovarian Cancer Paula Cunnea
EP1227 Nutritional Interventions to Improve Clinical Outcomes in Ovarian Cancer: A Systematic Review of Randomized Controlled Trials. Claudia Marchetti
EP1228 LIBUSE trial - Algorithm for cervical cancer screening in the Czech Republic with usage of HPV DNA testing with HPV 16/18 genotyping and p16/Ki-67 dual-stained cytology Jiri Slama
EP1229 Preventing Ovarian Cancer through early Excision of Tubes and late Ovarian Removal (PROTECTOR) Study Faiza Gaba
EP1230 Development of a Pragmatic Assay to Assess Homologous Recombination Competency in Endometrial Cancer. Claire Johanna Hermina Kramer
EP1231 Impact of Population Genetic Testing and Ovarian Cancer Risk Stratification on the Emotional Well-being and Health of Unselected Women in a General Population Faiza Gaba
EP1232 The next generation sequencing of cancer-related genes in small cell neuroendocrine carcinoma of the cervix Xuan Pei
EP1233 Wide variation in self-management skills in gynaecological cancer survivors from the Netherlands, Denmark and Norway – first results from the InCHARGE study Belle H de Rooij
EP1242 Palbociclib in the treatment of metastatic breast cancer. Institutional experience Andrea Mainella
EP1243 Anthropometric marker of breast cancer Alibha Rawat
EP1244 Populational trends and outcomes of postoperative radiotherapy for high-risk early-stage cervical cancer with lymph node metastasis: concurrent chemo-radiotherapy versus radiotherapy alone Maximilian Klar
EP1245 Topical Imiquimod treatment of high-grade cervical intraepithelial neoplasia (TOPIC-3) study: a multicentre, non-randomized controlled study Natasja Hendriks
EP1246 Role of transforming growth factor beta 1 (TGF-β1) polymorphisms in susceptibility to cervical cancer: a case-control study Mohd Nazmul Hasan Apu
EP1247 Early-stage cervical cancer outcomes after open, minimally invasive and vaginal surgery. Single centre experience Sergi Fernandez-Gonzalez
EP1248 Laparoscopic radical hysterectomy for early stage cervical cancer Nghia Doan Trong
EP1249 Correlation between cytological and histological characteristics of abnormal cervical smears Savvas Argyridis
EP1250 Distribution of stages of cervical cancer in a University Hospital of Dhaka, Bangladesh Sabera Khatun
EP1251 The robotic surgical management of upper paraaortic lymph node recurrancy of uterine cervical cancer in lateral decubitus position - Video presentation Fuat Demirkiran
EP1252 Magnetic resonance fingerprinting of cervical carcinoma- a feasibility study Elaine Yuen Phin Lee
EP1253 A novel model to predict cancer-specific survival in patients with early-stage uterine papillary serous carcinoma (UPSC) Chen Lihua
EP1254 Pericardial effusion by neoplastic infiltration as one of first clinical manifestation of metastatic uterine carcinosarcoma Osmar Ferreira Rangel Neto
EP1255 The effect of lymph vessel invasion on the survival rate in low-risk endometrial cancer Siarhey Taranenka
EP1256 Long-term results of high-risk stage I endometrial cancer depending on the morphological tumor type Siarhey Taranenka
EP1257 High grade endometrial stromal carcinoma: rare but challenging diagnosis in nulliaprous women requesting conservative surgery, a case report Amna Khalifa Tellisi
EP1258 Predictors of node metastasis in endometrial cancer at an early stage Elga Lopez Gonzalez
EP1259 Predictors of the endometrium cancer recurrence Elga Lopez Gonzalez
EP1260 Endometrium cancer and its features in our enviroment Elga Lopez Gonzalez
EP1261 Malignization of abdominal wall endometriom case report Alexandra Córdoba
EP1262 Cervical cancer during pregnancy and diagnostic problems – a case report Aneta Słabuszewska-Jóźwiak
EP1263 Adnexial mass at pregnancy: case report series Esra Keleş Peker
EP1264 Simultaneous integrated intensity modulated radiotherapy boost for gynecological cancer when brachytherapy is not an option: presentation of nine cases Eda Kucuktulu
EP1265 Advanced bipolar seal and cut technology device (Caiman®) versus traditional bipolar electrosurgery in laparoscopic hysterectomies Damir Danolić
EP1266 Assessment of effectiveness of post-operative triptorelin administration in alleviating gastrointestinal symptoms in patients with deep infiltrating endometriosis in a multicentre, non-interventional study Xinmei Zhang
EP1267 Assessment of efficacy of post-operative triptorelin in improving pain symptoms from deep infiltrating endometriosis: a 24-month multicentre, prospective, non-interventional study in highest pain intensity patient population Xinmei Zhang
EP1268 Burden of female genital tract malignancies at a tertiary care teaching hospital Priyanka Bharti
EP1269 Quality of life after surgery of varying surgical complexity in advanced ovarian cancer: results from the international, prospective, multicenter cohort SOCQER2 study Sudha Sundar
EP1270 Risk of ovarian cancer in women with histological proven endometriosis. The ENOCA a population-based cohort study Marjolein Hermens
EP1271 Prognostic implications of histological tumor regression (Böhm´s score) in patients receiving neoadjuvant chemotherapy for high grade serous tubal & ovarian carcinoma Anastousis Tranoulis
EP1272 Loss of fragile histidine triad protein expression is associated with homologous recombination deficiency in high-grade serous ovarian cancer Nanna Sarvilinna
EP1273 Fertility preservation in malignant ovarian tumors: experience of the French ESGO labeled –ovarian tumours center and pregnancy associated cancer network (CALG) national expert center at Tenon University Hospital Agathe Lier
EP1274 Distribution of histopathology types in stage 1A ovarian cancer Fani Kokka
EP1275 Concordance of peritoneal cancer index using a two-step surgical protocol to select patients for cytoreductive surgery in ovarian cancer Martina Angeles
EP1276 Microinvasive tubal carcinomas: cases of poor outcome despite ‘very early’ diagnosis. A systematic review of the literature Sabrina Piedimonte
EP1277 Clinical evaluation of miR-34a in ovarian carcinoma Dimitrios Papatheodorou
EP1278 Sentinel lymph node technique in early stage ovarian cancer (SENTOV): a phase II clinical trial Victor Lago
EP1279 The role of HE4 for prediction and prognosis of recurrence for different histologic subtypes of epithelial ovarian cancer- results from single institution Aleksandra Strojna
EP1280 Thrombocytosis in ovarian tumours: a single institute experience Aneta Slabuszewska-Jozwiak
EP1281 Total parietal peritonectomy: what morbidity? and which sites of recurrence? Delphine Hudry
EP1282 Evaluation of factors predicting recurrence in borderline ovarian tumors Vandana Jain
EP1283 Preliminary experience in the use of J-Plasma device in gynecological malignancies Salvatore Gueli Alletti
EP1284 Does co-administration of Resveratrol (RSV) and Cisplatin (CP) protects against Cisplatin ‐induced ovarian and uterine toxicities in female Westar rats? Ibrahim Albahlol
EP1285 Pregnancy and epithelial ovarian cancer: case report Tatiana Quijano
EP1286 Single institution experience with neoadjuvant chemotherapy compared to primary debulking surgery in patients over 75 with high grade ovarian cancer Sabrina Piedimonte
EP1287 A unique case report: postoperative palmar digital thrombophlebitis in a young primer Sjögren’s syndrome patient with high grade serous ovarian cancer Esra Keles
EP1288 The role of angiogenesis in early detection of epithelial ovarian carcinoma (EOC) - VEGF D (vascular endothelial growth factor D) as a potential novel biomarker Monika Nalezinska
EP1289 When ovarian cancer surgery cannot be achieved: an interview study of patient perspectives Lene Seibæk
EP1290 The possible role of cell polarity for cancer disease – the implication of cancer regression by human body axes interaction Ming Cheh Ou
EP1291 What factors affect quality of life in patients with gynaecoloc cancers? A prospective cohort study at the University Hospital of the West Indies Natalie Medley
EP1292 Minimally invasive palliative treatment of vulval cancer: is there a role for electrochemotherapy? Anastasios Tranoulis
EP1293 Medical treatment of vaginal intraepithelial neoplasia (VaIN): evaluating the efficacy and safety of 5-flouorouracil (5-FU) Anastasios Tranoulis
EP1294 Vulvar melanoma: case report Tatiana Quijano
EP1295 Primary vaginal Non-Hodgkin´s lymphoma: a case report of a rare entity Osmar Ferreira Rangel Neto
Paper Posters Day 1
Paper Posters Day 2

You may also like


Reasons to Attend

ESGO 2019 webcasts

ESGO 2024

Scientific Programme Highlights


Explore it Now!

WhatsApp Image 2023-10-01 at 17.27.08

Photo Gallery

Great moments from ESGO 2023!


View it Now!



Register Early & Save!


Register Now!